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SUMMARY 
Encapsulation of biomolecules within microcapsules has seen tremendous progress in 
the biomedical field, such as in bioanalysis, bioreactor and drug delivery applications, and 
is a growing interest amongst researchers in the recent years. The popularity of 
microcapsules stems from its minute nature that allows for efficient exchange of materials 
between the microcapsules and its environment. Core-shell materials, a sub-class of 
microcapsules, are commonly employed for the encapsulation of biomolecules due to the 
mechanical stability these microcapsules can provide. The “matrix-assisted Layer-by-
Layer (LbL) encapsulation” technique, performed in an aqueous dispersant, is an example 
of hydrogel core-shell materials fabricated for the encapsulation of biomolecules. 
However, biomolecule encapsulation problems (e.g. low encapsulation efficiency, poor 
control on encapsulated biomolecules quantity or poor retention stability) are associated 
with using current aqueous phase encapsulation techniques. The use of an organic phase 
for fabrication of core-shell materials and encapsulation of biomolecules is rarely 
demonstrated. Therefore, this PhD work involves the novel organic phase fabrication of 
core-shell materials and encapsulation of biomolecule with high encapsulation efficiency 
and retention stability.  
 
Desired biomolecules are first pre-loaded into agarose microbeads fabricated via a water-
in-oil emulsion technique. Using an emulsion technique allows all pre-mixed 
biomolecules within the hydrogel solution to be pre-loaded into the the resultant hydrogel 
microbeads. Following, these agarose microbeads are stabilized in anyhydrous 1-butanol 
by depositing amino-polystyrene microparticles along the periphery and surface of each 
  v
microbead. Termed as ‘matrix-assisted colloidosomes (MACs)’, the surfaces of these 
microparticles stabilized agarose microbeads were next deposited with polymers (non-
ionized polyallylamine (niPA) and poly(acrylic acid) (niPAA) ) dissolved in 1-butanol, via 
the Reverse-Phase LbL technique, for the fabrication of polymeric shells around each 
MAC core template. It was demonstrated that a high encapsulation efficiency of 
biomolecules could be obtained through the organic phase fabrication MAC RP-LbL core-
shell materials; and with almost 100% retention stability after 7 days incubation in an 
aqueous dispersant. In addition, encapsulated glucose oxidase (GOx) and horseradish 
peroxidise (HRP) could retain their bioactivity in these MAC RP-LbL core-shell 
materials. Asides from microparticles, ADOGEN
®
 464 (a cationic surfactant) was also 
used to stabilize these agarose microbeads in 1-butanol. High retention stability of dextran 
(> 500,000 Da) was observed but poor retention stability of dextran (< 155,000 Da) was 
observed for agarose (core) RP-LbL (shell) microcapsules fabricated using ADOGEN
®
 
464 and the RP-LbL technique. This highlights that the use of agarose (core) RP-LbL 
(shell) microcapsules fabricated using ADOGEN
®
 464 and the RP-LbL technique is more 
suitable for encapsulating higher MW biomolecules with high retention stability.  
 
Remarkably, incubation of only niPA with agarose microbeads in 1-butanol (as solvent 
and dispersant respectively) results in a thick uniform polymeric layer forming in the 
peripheral matrix around each core microbead. This novel polymeric shell fabrication 
technique is driven by diffusion and is termed as the “inwards deposition of concentric 
niPA layers” technique. Upon stabilization of these layers into shells, with a cross-linker, 
these core-shell materials could be stably dispersed in an aqueous phase and were 
demonstrated to be capable of encapsulating and retaining pre-loaded low MW FITC-
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dextran (4,000 Da). The retention efficiency was determined to be ~95% after a 5 days 
incubation period in an aqueous dispersant. Separate incubation of niPA or niPA 
conjugated with a dye (FITC or TRITC), inclusive of washing steps, results in the 
fabrication of shells consisting of distinct coloured striated layers. Permutation of the 
color sequence allows for encoding purposes. It was also demonstrated that the thickness 
could be tuned, through manipulation of niPA volume or incubation time, and would 
therefore allow for an agarose core-shell microcapsule encoding system with at least 2 
levels of encoding. Lastly, encapsulated GOx and HRP were demonstrated to have 
retained their bioactivity in these unique encoded core-shell materials and further highlight 
the potential of utilizing the “inwards deposition of concentric niPA layers” technique for 
potential multiplexing applications. 
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Chapter 1 – Introduction 
 Microcapsule research has seen tremendous progress over the recent years in many 
biomedical applications such as cellular therapeutics (Joki et al., 2001; Murua et al., 2007; 
Prakash and Chang, 1996), drug delivery (Dai et al., 2004; Park et al., 2005; Qiu et al., 
2001; Skirtach et al., 2006; Wang et al., 2007), bioreactors (Lvov, et al., 2001; Mak et al., 
2008a), biosensors (Brown et al., 2005) and bioanalytics (Kreft et al., 2007a; Rijiravanich 
et al., 2008). With diameters in the micrometer range and the ability to encapsulate 
materials, microcapsules possess a large surface-area-to-volume ratio that allows efficient 
exchange of materials with the surroundings for the many applications as described. 
Taking the work of Mak et al. (2008a) as an example: deoxyribonucleic acids (DNA) 
polymerase, primers (designed for a specific target sequence) and the target DNA were 
encapsulated within agarose microcapsules. Upon subjecting these microcapsules to 
thermal cycling in a solution of nucleotides, the process of polymerase chain reaction 
could undergo within these microcapsules as the nucleotides could freely diffuse into and 
out of the microcapsules. This produces duplicates of the target DNA fragment and 
demonstrates the use of microcapsules as possible vessels for bio-reactions and DNA 
duplication. One common challenge that is prominent in all these applications, when 
biomolecules are encapsulated within the microcapsules, is the need to ensure that the 
biomolecules remain entrapped within the microcapsules and retain their bio-functionality. 
Simultaneously, it is also necessary for small molecular weight species (e.g. nucleotides, 
glucose, ions) to be able to diffuse freely in and out of the microcapsules, through the 
shell, especially in the bioreactors, biocatalysis and bioanalytics applications. 
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Currently, the most common method to fabricate microcapsules and to perform 
encapsulation of biomolecules is through the self-assembling of polymers; which is well 
known as the Layer-by-Layer (LbL) method (Decher, 1997). In this method, polymers 
(usually of opposite charges) are alternately deposited onto a core template for the 
fabrication of a “semi-permeable membrane” around the template; where the “semi-
permeable membrane” will entrap the large molecular weight biomolecules within while 
allowing the free diffusion of small molecular weight species (Sukhorukov et al., 1999, 
2000). The template is subsequently removed which may then be loaded with 
biomolecules (Ghan et al., 2004; Kreft et al., 2006; Lvov et al., 2001). Alternatively, the 
template could be microcrystals of the biomolecules where the deposition of the polymers 
is done in special conditions to prevent dissolution of the microcrystals (Beyer et al., 
2007; Trau and Renneberg, 2003). Direct deposition of the polymers would encapsulate 
the biomolecules and thereby forms the microcapsules. However, removal of the template 
or transferring the encapsulated biomolecule microcrystals into an aqueous phase (and 
thereby the dissolution of the highly water soluble microcrystals) would result in the 
formation of hollow microcapsules which are mechanically unstable and have a tendency 
to collapse. In order to enhance the rigidity and mechanical stability, core-shell materials, 
such as agarose LbL microcapsules (Mak et al., 2008a, 2008b) (termed as “matrix-assisted 
LbL”), have been used. Hydrogels possess certain advantages such as the ability to 
contain a high percentage of water that provides a favorable environment for the 
encapsulated biomolecules. Loss of biomolecules during the phase of LbL polymer 
deposition and “semi-permeable membrane” fabrication is unfortunately too significant 
and results in low encapsulation efficiency of the biomolecules (Mak et al., 2008a). 
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The use of an organic phase for the fabrication of hydrogel core-shell materials could 
achieve high encapsulation efficiency of biomolecules. In addition, using a hydrophobic 
solvent for fabrication of hydrogel core-shell materials is an uncharted area and where 
different polymer interactions or phenomenon can be explored, thus resulting in 
fabrication of novel core-shell materials.  
 
The objective of this work is therefore to study and perform the organic phase 
fabrication of core-shell materials for encapsulation of biomolecules. 
 
This PhD thesis is organized in the following manner: 
1) Chapter 1 –   Introduction 
2) Chapter 2 –   Literature Review 
3) Chapter 3 –   Objective and Specific Aims 
4) Chapter 4, 5, 6 and 7 –  Results and Discussion 
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Chapter 2 – Literature Review 
2.1 Introduction  
Microcapsules can be defined as encapsulation vessels existing in the micrometer 
range and with two broad classifications: 1) hollow microcapsules and 2) core-shell 
microcapsules. In the biomedical field, microcapsules are a field of immense research due 
to the many possible applications where these microcapsules can be used, such as in 
cellular therapeutics (Joki et al., 2001; Murua et al., 2007; Prakash and Chang, 1996), 
bioreactors (Antipov et al,. 2003a; Mak et al., 2008a; Shchukin and Sukhorukov, 2004), 
drug delivery (Dai et al., 2004; Park et al., 2005; Skirtach et al., 2006), vaccine delivery 
(Rose et al., 2008), bioanalytics (Kreft et al., 2007a; Rijiravanich et al., 2008), 
biomimetics (Duan et al., 2007b) and cell targeting (Cortez at al., 2006; Fischlechner et 
al., 2005). The popularity of microcapsules stems from its minute nature and the ability to 
allow efficiency exchange of materials between the microcapsules and the environment. 
Also, encapsulation of cells and biomolecules within microcapsules can reap many 
benefits such as protection of the encapsulated materials against the environment (dilution 
effects, inhibitors, proteases or bacteria contamination), close interaction between the 
encapsulated materials (allowing for rapid intercalating reactions) and the incorporation of 
magnetic nanoparticles within the architecture of the microcapsules for specific location 
targeting (Zebli et al., 2005). 
 
In this chapter, different techniques for the fabrication of microcapsules will be discussed. 
Following, the fabrication of hollow or core-shell microcapsules via the Layer-by-Layer 
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(LbL) technique (which can be considered to be the state-of-art technology) will be 
reviewed and how this popular class of microcapsules has been used in the encapsulation 
of biomolecules for bio-applications. 
 
2.2 Techniques for the Fabrication of Microcapsules 
In this section, the fabrication of microcapsules via self-assembled phospholid 
bilayers, solvent evaporation, interfacial assembly of microparticles, interfacial 
polymerization and the LbL technique will be reviewed. 
 
2.2.1 Self-Assembled Phopholipid Bilayers (Liposomes) 
Liposomes are composed of bilayer phospholipids assembled together to form a closed 
spherical structure. Fabrication of these microcapsules can be done via the use of 
emulsification techniques such as sonication followed by the extrusion method to acquire 
similar sized liposomes (Olson et al., 1979). These phospholipid vesicles have been 
demonstrated to be capable of encapsulating several types of materials such as enzymes 
(Chaize et al., 2004), anti-tumour drugs (Zhigaltsev et al., 2005) and therapeutic drugs 
(Nii and Ishii, 2005). Using different membranes of different pore sizes in the extrusion 
method will result in liposomes of different sizes but with similar size distribution. As 
such, liposomes can be obtained with a range from tens to thousands of nanometers and 
the nanometer sized liposomes are particularly useful for the application in drug 
applications. However, liposomes are generally unstable and have a tendency to fuse 
together. 
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2.2.2 Solvent Evaporation 
Microcapsules fabricated with polymeric shells are mechanically more stable than 
liposomes. One approach to fabricate such microcapsules is through emulsification of an 
oil phase (containing a good and poor organic solvent for the desired polymer that will 
form the shell) in an aqueous phase to form an oil-in-water emulsion, followed by 
evaporation of the good organic solvent (Dowding et al., 2004; Lavergne et al., 2007; 
Loxley and Vincent, 1998). As the good solvent (which has a lower boiling point) is 
gradually being removed from the emulsion by reducing the pressure and elevating the 
temperature, the polymer and good solvent begins to phase separate as small droplets 
within the oil phase. These small droplets would begin to migrate to the oil/water interface 
where they merge and eventually covers the surfaces of the oil phase. Further evaporation 
of the good solvent will result in precipitation of the polymer and this would eventually 
form microcapsules with polymeric shells and liquid oil cores, and which are useful for 
drug delivery applications. Instead of using oil-in-water emulsion, Atkin et al., 2004 
demonstrated the formation of microcapsules with an aqueous core and polymer shell 
through the use of water-in-oil emulsion. The same solvent evaporation and phase 
separation technique was applied where acetone was used as the good solvent and water as 
the poor solvent for the polymer. Although encapsulation of biomolecules using the 
solvent evaporation technique has been demonstrated (Kim et al., 2005), such works are 
uncommon. 
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2.2.3 Interfacial Assembly of Microparticles 
Another approach to fabricate microcapsules with polymeric shells is through 
manipulating the behavior of materials at the interface between two liquids. With the 
ability to function like surfactants, microparticles have been manipulated and self-
assembled at the interface of water and oil; and depending on their wettability to form 
either water-in-oil or oil-in-water emulsions (Binks, 2002.). Further stabilization of these 
microparticles at the surface of these emulsion droplets gives rise to colloidosomes or 
microcapsules with surface assembled microparticles as a polymeric shell (Velev at al., 
1996). 
 
Figure 2.1. Optical micrograph of a colloidosome. Image was obtained by a 3D 
reconstruction process of a series of optical micrographs (Cayre et al., 2004, Reproduced 
by permission of The Royal Society of Chemistry). 
 
Cayre et al. (2004) described the fabrication of colloidosomes with an agarose core and an 
integral shell of polystyrene (PS) latex beads (Figure 2.1). Agarose along with amino–PS 
particles were mixed and emulsified with oil by using a preheated syringe and needle. The 
emulsion was then left to stir at 75 
o
C to allow migration of the beads towards the 
interface before further cooling to room temperature to set the agarose gel. Addition of 
glutaraldehyde after cooling allowed cross-linking of the amine groups to occur, thus 
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stabilising the PS particle “shell”. Transfer of these colloidosomes into the water phase 
was demonstrated to be possible. Recently, Laib et al. (2008) fabricated colloidosomes at 
low temperature that allows the encapsulation of temperature sensitive biomolecules. The 
fabrication method involves emulsification as well but rather than using PS beads and an 
agarose core, they synthesized poly(styrene–co–butylacrylate) latex particles with a Tg of 
42 
o
C and used these particles to fabricate water-core colloidosomes. As the particles had 
relatively low Tg, they could be sintered at 50 
o
C, allowing stabilization of the 
colloidosomes. By using an appropriate surfactant, these colloidosomes could be 
stabilized in the aqueous phase. It has also been demonstrated that by changing the size of 
the colloid particles or allowing fusion of these particles, it allows one to manipulate the 
degree of permeability of these microcapsules (Yow and Routh, 2006) and thus making 
colloidosomes useful for release applications (Rosenberg and Dan, 2010; Yow and Routh, 
2009). This interfacial self-assembly phenomenon has even been extended to SU-8 
polymeric microrods for the fabrication of “hairy” colloidosomes (Noble et al., 2004). 
 
2.2.4 Interfacial Polymerization 
The polymerization of two different monomers at the interface of two immiscible 
liquids has also been used for the fabrication of microcapsules with polymeric shells 
(Ramarao et al., 2002; Sun and Deng, 2005; Torini et al., 2005). For example, 
microcapsules with polyurethane shells have been fabricated by interfacial polymerization 
of isophorone diisocyanate (IPDI) and 1,6-hexanediol (HDOH) (Torini et al., 2005). 
Cyclohexane was used as the oil phase and to dissolve IPDI. The cyclohexane containing 
the IPDI was then emulsified in water with a sonicator and HDOH, that is soluble in 
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water, was added next. This created many mini-droplets of cyclohexane suspended in 
water and allowed for the interaction and polymerization of IPDI and HDOH only at the 
surfaces of these cyclohexane mini-droplets, thus forming microcapsules with 
polyurethane shells. 
 
Aside from interfacial polymerization, the gelation of alginate at the interface of two 
immiscible liquids has been used to form microcapsules with polymeric alginate shells 
(Zhang et al., 2006). Through the use of microfluidics, alginate droplets were formed in 
undecanol that contained pre-dissolved calcium iodide. Subsequently, the calcium ions in 
the organic solvent partitions into the aqueous droplets and gels the alginate near the 
organic/aqueous interface to form alginate shells around the aqueous droplets. This 
method is particularly useful for the encapsulation of cells. 
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2.2.5 Layer-by-Layer (LbL) Technique 
 
Figure 2.2. Schematic illustration of the Layer-by-Layer (LbL) technique. Using a 
substrate with an overall positive surface charge as an example, a negative polyelectrolyte, 
poly(sodium 4-styrene-sulphonate) (PSS), is deposited onto the surface of the template to 
form the first polymer layer. Washing is performed to remove excess PSS before coating 
of a positively charge polyelectrolyte, poly (allylamine hydrochloride) (PAH), to form the 
second polymer layer. Washing is again performed before the cycle is repeated until the 
number of desired layers is obtained. (Decher, 1997, Reproduced by permission of The 
American Association for the Advancement of Science) 
 
Currently, the most popular technology for fabrication of hollow or core-shell 
microcapsules is via the Layer-by-Layer technology (Decher, 1997). This technology was 
first introduced in 1991 and is relatively simple as it relied on the interaction of oppositely 
charged polymers for the formation of the microcapsules. The process behind the LbL 
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technology is articulated in Figure 2.2. Briefly, using a template with a positive zeta 
potential as an example, a negatively charged polyelectrolyte, poly(sodium 4-styrene-
sulphonate) (PSS), is introduced to the template. Through electrostatic attraction and 
entropic considerations, the PSS deposits onto the surface of the template and forms the 
first stable polymer layer. Washing is performed to remove any excess and unbound PSS 
before the introduction of a second and oppositely charged polyelectrolyte, poly 
(allylamine hydrochloride) (PAH), for the adsorption of the second stable polymer layer. 
Washing is performed again after the adsorption of PAH and the polymer deposition cycle 
is repeated until the number of desired polymer layers is obtained. 
 
However, the technology of LbL has since evolved. Synthetic polymers are no longer the 
only possible polymer species able to perform LbL deposition. Bio-polymeric candidates 
including DNA (Johnston et al., 2005), proteins (Duan et al., 2007a; Shutava et al., 2006) 
and other biomacromolecules such as hyaluronic acid, poly-L-lysine, sodium alginate and 
chitosan (De Geest et al., 2006a; Lee et al., 2007; Shenoy et al., 2003) have been shown 
capable of forming multilayer films via the LbL technique. Also, asides from electrostatic 
interactions, other possible chemical means of LbL polymer deposition such as via 
hydrogen bonds (Kozlovskaya et al., 2003; Yang et al., 2004), click chemistry (Such et al., 
2006, 2007), host-guest chemistry (Wang, et al., 2008) and covalent bonding (Feng et al., 
2007; Tong et al., 2006; Zhang et al., 2003) have been demonstrated. Recently, it has also 
been demonstrated that the LbL coating technique can be performed by using an organic 
solvent (Beyer et al., 2007; Kamineni et al., 2007), or as coined by Beyer et al., 2007 - 
“Reverse-Phase LbL (RP-LbL)”. Through the use of organic solvents, the boundaries of 
LbL technique has been broadened and extended to the use of both non water-soluble 
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polymers for LbL self-assembly of polymers and highly water-soluble materials as core 
templates. More details regarding the recent developments of the LbL technique can be 
found in these excellent reviews (Quinn et al., 2007; Zhang et al., 2007). 
 
Advantages of the LbL technique include: 
1) no restriction with respect to template size and topology,  
2) many possible species may be used for the LbL process including synthetic 
polymers, inorganic materials & biomolecules,  
3) no tedious reaction and separation has to be carried out for each adsorption 
process, 
4) adsorption process is reproducible, 
5) preparation of multilayer structure with precise control over number of layers, 
6) thickness of each layer is approximately a 3-5 nm (Decher et al., 1992, 1994) and 
can be further tuned via parameters such as ionic strength (Serizawa et al., 2002), 
7) the amount of polymer deposited is a self-limiting process. 
 
Due to the huge library of “LbL candidates”, various polymer permutations and chemistry 
for layer interactions have been made possible. This has allowed the LbL technique to be 
applied in numerous research areas ranging from toxicity screening (Rusling et al., 2008), 
surface chemistry modification (Jaber and Schlenoff, 2006) to biomedical applications 
such as biomimetic, biosensors and tissue engineering (Tang et al., 2006). This technique 
is also an extremely popular technique for the fabrication of core-shell and hollow 
microcapsules for biomedical application and will be reviewed in the following section. 
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2.2.5.1 Core-Shell LbL Microcapsules  
The fabrication of core-shell materials via the LbL technique is a procedure that is 
technically simple and easy to perform. The material desired as the core is usually utilized 
as the template for the deposition of the polymer layers. Using the work of Mak et al., 
2008a as an example, agarose LbL microcapsules were fabricated through the aqueous 
phase LbL deposition of polymers onto the surfaces of agarose microbeads; where the 
agarose constituted the core and the polymers formed the shell. The agarose microbeads 
were fabricated through water-in-oil emulsion and as these microbeads were slightly 
negatively charged, a positively charged polymer was first deposited onto the microbeads’ 
surface by simply incubating the microbeads in a solution of the positively charged 
polymer. The microbeads were then washed thoroughly to remove excess positively 
charged polymers before being introduced into a solution of negatively charged polymers; 
where the negatively charged polymers deposited onto the surface of agarose microbeads 
via electrostatic interactions with the pre-deposited positively charged polymer. Excess 
negatively charged polymer is washed away and the polymer deposition cycle is repeated 
until the desired number of polymer layers for the polymer multilayer shell was achieved. 
Other core templates that have been demonstrated possible for the deposition of polymers 
via the LbL technique include highly water-soluble protein crystals (Beyer et al., 2007; 
Caruso et al., 2000b; Trau and Renneberg, 2003), poorly water-soluble organic crystals 
(Caruso et al., 2000b; Trau et al., 2002), calcium alginate (Srivastava et al., 2005) 
microbeads and calcium carbonate (Antipov et al., 2003b; Volodkin et al., 2004a), 
polystyrene (PS) (Zhang et al., 2003; Yu et al., 2008), melamine formaldehyde (MF) 
(Balabushevich et al., 2003; Gao et al., 2002a, 2002b; Radtchenko et al., 2000), gold 
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(Gittins and Caruso, 2000, 2001) or silica (Johnston et al., 2005; Kozlovskaya and 
Sukhishvili, 2006) micro/nano particles. Advantages of using calcium carbonate, 
melamine formaldehyde, gold and silica particles include the availability of these 
templates with near uniform dimensions and in the region of nano – micrometers for 
fabrication of core-shell materials. 
 
2.2.5.2 Hollow LbL Microcapsules 
Fabrication of hollow LbL microcapsules requires the exact procedures for the 
fabrication of core-shell LbL microcapsules with the inclusion of an additional template 
sacrificial step that removes the template and thus resulting in hollow LbL microcapsules 
(Donath et al., 1998). This sacrificial process will only decompose the template and does 
not affect the integrity of the LbL capsular wall, therefore allowing the decomposed 
template to diffuse out of the LbL capsular wall and for the surrounding buffer to diffuse 
in. Common sacrificial templates used for the fabrication of hollow LbL microcapsules 
include calcium carbonate, PS, MF and silica micro/nano particles. The calcium 
carbonate, PS, MF and silica templates can be removed with ethylenediaminetetraacetic 
acid (EDTA), tetrahydrofuran, under acidic condition and hydrofluoric acid respectively. 
Unlike core-shell LbL microcapsules, hollow LbL microcapsules are mechanically weaker 
and might have a tendency to collapse or rupture. Also, the use of toxic chemicals like 
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Advantages of the LbL technique in the fabrication of microcapsules include: 
1) the multilayer polymer shell formed can serve as a “semi-permeable membrane” 
that encapsulates large molecular weight species within the microcapsule while 
allowing the passage of small molecular weight species through (Sukhorukov et 
al., 1999, 2000) 
2) the surface property of the multilayer polymer shell can be altered and depends on 
the last layer which was deposited. For example, the surface charge depends on the 
charge of the outermost polymer layer deposited and can therefore be easily altered 
(Ladam et al., 2000; Sukhorukov et al., 1998). Also, incorporation of either low-
biofouling (Ochs et al, 2008) or cell targeting capabilities (Cortez at al., 2006; 
Fischlechner et al., 2005) through manipulation of the outermost layer is especially 
useful in bio-medical applications 
3) the properties of the multilayer polymer shell can be easily manipulated by 
surrounding factors. For example, LbL “semi-permeable membranes” shells can be 
fabricated such that the porosity of the “membranes” changes either when the 
temperature (Glinel et al., 2003; Köhler and Sukhorukov, 2007), solvent (Dong et 
al., 2005; Lvov et al., 2001), ionic strength (Georgieva et al., 2002) or pH (Antipov 
et al., 2002; Déjugnat et al., 2005) of the environment changes. The LbL polymer 
multilayer shell can also be fabricated such that it can disintegrate upon light 
activation (Skirtach et al., 2004, 2005) or in the presence of certain bio-analytes 
(De Geest et al., 2006b; Levy et al., 2008). 
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2.3 Encapsulation of Biomolecules within LbL Microcapsules 
The following section of this literature review will specifically cover the encapsulation 
of biomolecules within core-shell and hollow microcapsules fabricated via the LbL 
technique. 
2.3.1 Encapsulation in Core-Shell LbL Microcapsules 
Encapsulation of biomolecules in core-shell LbL microcapsules can be generalized 
into three categories: 1) direct template, 2) pre-loading and 3) mesoporous microparticles. 
 
2.3.1.1 Direct Template Encapsulation 
Encapsulation of biomolecules into microcapsules can be performed via the direct LbL 
deposition of polymers onto biomolecule microcrystals to achieve high encapsulation 
efficiency. However, this method cannot be applied in simple aqueous conditions as these 
microcrystals are highly soluble in an aqueous solvent and would dissolve. To prevent the 
dissolution of these highly water-soluble biomolecule microcrystals, these microcrystals 
can be stably dispersed in chilled high salt aqueous solutions (Caruso et al., 2000b; Trau 
and Renneberg, 2003) or in organic solvents such as ethanol (Beyer et al., 2007). Since the 
microcrystals remain solid while in these conditions, polymers can either be deposited 
onto the templates via the conventional aqueous LbL techniques or the Reverse-Phase 
LbL (RP-LbL) technique (Figure 2.3) and thus forming the core-shell LbL microcapsules. 
Direct fabrication of microcapsules from microcrystal templates allows for the fabrication 
of microcapsules loaded with a very high concentration of water soluble biomolecules. 
However, preparation of core-shell LbL microcapsules encapsulating mixtures of 
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biomolecules, with defined concentration, by this approach is difficult as “hybrid” micro-
crystals consisting of a mixture of various biomolecules with defined concentration are 
difficult to prepare. 
 
Figure 2.3. Schematic illustration of the Reverse-Phase LbL (RP-LbL) technique for 
encapsulation of biomolecules in an organic solvent. i & ii) Deprotonation of cationic and 
protonation of the anionic polyelectrolyte and dissolution in an organic solvent. iii) 
Preparation of a suspension of highly water soluble biomolecules in an organic solvent. iv) 
Deposition of the first non-ionized polyelectrolyte v) Deposition of alternating layers of 
non-ionized cationic and anionic polyelectrolytes to form a multilayer polymeric shell. vi) 
Transfer of the encapsulated material from the organic phase into another organic solvent 
(left) or into an aqueous phase (right). (Beyer et al., 2007, Reproduced by permission of 
American Chemical Society) 
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2.3.1.2 Pre-loading Encapsulation 
The second approach for the encapsulation of biomolecules into core-shell 
microcapsules involves the pre-loading of biomolecules within the core template during 
the fabrication of the core template prior to the deposition of polymers, via the LbL 
technique, onto these biomolecule loaded templates. Examples of possible templates that 
have been demonstrated possible for this approach include carbonate (Kreft et al., 2007b; 
Borodina et al., 2007; Petrov et al., 2005) and hydrogel microbeads (Mak et al., 2008a, 
2008b). Pre-loading of biomolecules in carbonate microparticles is a “gentle” process and 
involves the co-precipitation of biomolecules with the growing carbonate microparticles 
when a solution of carbonate salt (e.g. Na2CO3) is mixed with a solution of a cation 
chloride (e.g. CaCl2) solution containing the biomolecules. Pre-loading of biomolecules 
into hydrogel microbeads prior to the deposition of polymers via the LbL technique, or 
termed as “matrix-assisted LbL encapsulation technique”, involves the emulsification of a 
hydrogel solution containing the biomolecules in an oil phase, followed by gelation of the 
hydrogel droplets to form hydrogel microbeads pre-loaded with biomolecules (Figure 2.4). 
The use of a hydrogel template has a significant advantage where the aqueous make-up of 
the hydrogel microbead can be as high as 90% and thereby providing a suitable 
environment for bio-reactions to take place. In addition, pre-loading via an emulsification 
approach ensures that all biomolecules are pre-loaded into the hydrogel microbeads and 
not wasted. However, the “matrix-assisted LbL encapsulation technique” does not allow 
for high encapsulation efficiency of biomolecules as these biomolecules leaches out into 
the aqueous environment during the deposition of polymers via the LbL technique (Mak et 
al., 2008a). 
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Figure 2.4. Schematic illustration of the “matrix-assisted LbL encapsulation” technique. 
From left to right: Mixing of matrix material (e.g. agarose) and biomolecules (e.g. 
polymerases and primers) followed by emulsification in an oil phase to form water-in-oil 
emulsion. Solidification of the matrix to allow deposition of polymers via the LbL 
technique for the encapsulation and retention of the biomolecules within the matrix 
microbeads (Mak et al., 2008, Reproduced by permission of Wiley-VCH Verlag GmbH & 
Co. KGaA). 
 
2.3.1.3 Mesoporous Microparticles 
The last approach for the encapsulation of biomolecules into core-shell microcapsules 
involves the aqueous incubation of the desired biomolecules, to be encapsulated, with 
calcium carbonate (Volodkin et al., 2004b) or mesoporous microparticles (Wang and 
Caruso, 2004; Yu et al., 2005); where the biomolecules would diffuse into the pores 
present within these microparticles and physically adsorbed (electrostatic interactions) 
onto the external surfaces of these microparticles and the internal walls of the pores. These 
biomolecules loaded microparticles are then subjected to polymer deposition via the LbL 
technique for the fabrication of core-shell materials and encapsulation of these 
biomolecules. Although loading of biomolecule via diffusion and adsorption is a simple 
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procedure, it is difficult for one to control the quantity of biomolecules to be pre-loaded 
into these mesoporous microparticles. 
 
2.3.2 Encapsulation in Hollow LbL Microcapsules 
Encapsulation of biomolecules in hollow LbL microcapsules can be divided into two 
categories: 1) Pre-loading within sacrificial microparticles and via 2) diffusion into hollow 
LbL microcapsules. 
 
2.3.2.1 Pre-loading within Sacrificial Microparticles 
An approach for the encapsulation of biomolecules in hollow LbL microcapsules can 
be performed by preloading these biomolecules into sacrificial microparticles (e.g. 
carbonate and silica microparticles), deposition of polymers onto these sacrificial 
microparticles via the LbL technique for the fabrication of “semi-permeable membrane” 
shells and followed by removal of the sacrificial microparticles. Removal of the 
microparticles results in hollow LbL microcapsules containing the biomolecules within 
the hollow aqueous core. Methods for the preloading of biomolecules into carbonate and 
silica microparticles have been covered in Section 2.3.1.2/2.3.1.3, and methods for the 
removal of these sacrificial microparticles has been covered in Section 2.2.5.2. 
 
2.3.2.2 Diffusion into Hollow LbL Microcapsules 
The second approach to encapsulate biomolecules within hollow LbL microcapsules 
can be achieved through the initial fabrication of hollow LbL microcapsules (covered in 
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Section 2.2.3.2) followed by the loading of biomolecules into the hollow aqueous core via 
diffusion of the biomolecules from an external solution. Diffusion occurs through the LbL 
“semi-permeable membrane” shells and into the core (Figure 2.5), and is driven by a 
concentration gradient. Retention of these biomolecules can be achieved inside these 
hollow LbL microcapsules either via formation of a complex within the core (Gao et al., 
2002a, 2000b) or by manipulating the permeability of the LbL “semi-permeable 
membrane” shells though pH (Ghan et al., 2004), solvent (Lvov et al., 2001), drying 
(Kreft et al., 2006), ionic strength (Georgieva et al., 2002) or ultraviolet irradiation (Zhu 
and McShane, 2005) means. 
 
Figure 2.5. Schematic illustration of protein deposition into hollow LbL microcapsules 
via diffusion. From left to right: fabrication of hollow LbL microcapsules from MF 
templates with a negative polymer(PSS)/MF complex within the core of the hollow 
microcapsules. Introduction of the hollow microcapsules into a solution of protein with 
positive charge will result in the diffusion of the protein into the microcapsule and 
complexing with the PSS/MF complex. The complexed protein will therefore retain within 
the microcapsules (Gao et al., 2002b, Reproduced by permission of The Royal Society of 
Chemistry). 
 
Formation of complexes within the hollow core for biomolecule encapsulation and 
retention can be achieved through the use of MF microparticles as the sacrificial template. 
As MF microparticles possess a positive zeta-potential, it is necessary to perform the 
deposition of polymers via the LbL technique with an initial negative polymer such as 
Chapter 2 – Literature Review 
 22
PSS. Once the desired number of layers has been deposited, the MF microparticles is 
decomposed and removed. Concomitantly, the 1
st
 layer of PSS partially dissociates from 
the fabricated LbL “semi-permeable membrane” shells and is released into the interior 
where it complexes with the positively charged MF degradation product. This PSS/MF 
complex has an overall negative charge and is too large in size to diffuse through the LbL 
shells. Upon incubation of these hollow LbL microcapsules with biomolecules of positive 
charge, the biomolecules gets driven by an electrochemical gradient into the core of the 
microcapsules and deposits within the core by complex formation with the negatively 
charged PS/MF complex. Though encapsulation and retention of biomolecules requires 
the formation of a complex with the PSS/MF complex, encapsulation of enzymes have 
been demonstrated to be capable of retaining their bioactivity (Gao et al., 2002b). 
However, the requirement of complex formation limits this method to biomolecules that 
possess an overall positive zeta-potential (i.e. encapsulation of native DNA will not be 
possible). 
 
Alternatively, biomolecules can be encapsulated and retained within hollow LbL 
microcapsules after diffusion by manipulating the permeability of the LbL “semi-
permeable membrane” shells. The LbL shells can initially be impermeable to the 
biomolecules and requires “turning on” to increase permeability. Examples of parameters 
that increase LbL shell permeability include drying, solvent change and changes in pH or 
ionic strength of the external solution. Once the permeability has been sufficiently 
increased, the biomolecules will begin to diffuse through the LbL shells and accumulate 
within the core of the hollow LbL microcapsules until equilibrium of biomolecules 
concentration between the core and external solution is established. The “turning on” 
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stimuli is then removed which subsequently reduces the permeability of the LbL shells 
and thereby locks the biomolecules within the core of hollow microcapsules. On the other 
hand, the LbL shells may initially be permeable to the biomolecules and requires “sealing” 
methods (such as UV polymerization of the LbL shells) to lock the biomolecules within 
the hollow LbL microcapsules. 
 
Unfortunately, the concentration of the loaded biomolecules via diffusion means is limited 
to the concentration of biomolecules in the external solution. Therefore, not all 
biomolecules will be encapsulated and this results in wastage. 
 
2.4 Applications of Biomolecules Loaded LbL Microcapsules 
2.4.1 Biosensors 
A valuable application of microcapsules in the biomedical field is the use of these 
microcapsules as biosensors. Being minute in nature and thus allowing efficient exchange 
of materials with the environment, microcapsule biosensors can respond quickly to 
changes of the environment and produce the corresponding signal output. The works of 
Brown et al (2005) described an oxygen-quenching fluorophore (ruthenium-tris(4,7-
diphenyl-1,10-phenanthroline) dichloride) and glucose oxidase (GOx) encapsulated within 
a calcium alginate LbL microcapsule for the detection of glucose. GOx was loaded within 
the alginate microbead during the emulsification process and encapsulated after the 
application of the LbL technique; whereas the fluorophore was loaded into the core after 
the alginate LbL microcapsules were fabricated and entrapped through precipitation with 
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the anionic alginate matrix. The measurement of glucose was indirect as the analytical 
system measured the amount of oxygen present rather than the amount of glucose present. 
As the concentration of oxygen decreases within the capsule due to the oxidation of 
glucose by GOx, this causes the fluorescence intensity of the fluorophore to increase. By 
incorporating a computational model of this system, the theoretical and experimental data 
were compared and were in close agreement with each other. The experimental plot was 
an increasing linear graph with a R
2
 value of 0.9379 over a glucose range of 0 – 30 mM.  
 
In the same year, Chinnayelka et al (2005) developed a glucose microcapsule sensor using 
FRET as its principle of detection instead. TRITC–Apoenzyme GOx, along with FITC–
dextran, were used for the FRET system as apoenzyme GOx has a much higher specificity 
for β-D-glucose when compared to the native GOx. The FRET system was encapsulated 
in diazoresin-based LbL hollow microcapsules whereby diffusion preloading of the 
analytical system was performed prior to “sealing” of the polymeric shell. The 
microcapsule analytical system showed a sensitivity ranging from 2 – 6 (% change in 
FITC/TRITC peak ratio) mM
-1
 over a glucose concentration range of 0 – 40 mM.  
 
2.4.2 Bioreactors 
Performing bioreactions in microcapsules is a research area of intensive investigation 
as it may allow easy retrieval of reaction products or hassle-free recycling of the 
biomolecules within the microcapsules after completion of the bioreaction by simply 
extracting the microcapsules, and offers the possibility of mimicking cellular organelles in 
the future. Demonstration of microcapsule bioreactors has been successfully demonstrated 
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through the encapsulation of urease (Lvov et al., 2001) and hydrogen peroxidase (Ghan et 
al., 2004) enzymes for the hydrolysis of urea and polymerization of phenols respectively. 
 
An extremely useful bioreactor application of LbL microcapsules loaded with 
biomolecules was recently demonstrated (Mak et al., 2008a). The LbL microcapsules were 
fabricated and loaded with polymerase, DNA templates and primers as shown in Figure 
2.4 and could be used as vessels to perform polymerase chain reactions (PCR). 
Nucleotides were provided for the PCR reaction by an external solution as these 
molecules are relatively small and could easily diffuse through the LbL “semi-permeable 
membrane” shell to enter the microcapsules. As thousands of LbL microcapsules could be 
easily fabricated, this would allow for many more PCR reactions to be conducted 
simulateneously in a typical thermo-cycler as compared to the conventional tube PCR 
technique. It was successfully demonstrated that each LbL microcapsule was capable of 
replicating the PCR reaction without any interference from other microcapsules (i.e. no 
exchange of primers occurred during the PCR temperature cycle); and as the replicated 
DNA would remain entrapped within the LbL microcapsules, the respective microcapsules 
containing these DNA could be identified via fluorescence nucleotides and extracted to 
retrieve the synthesized DNA. Such a procedure would allow for future health screening 
or diagnostic tests. 
 
2.4.3 Drug Releasing/Therapeutics 
Another useful application of LbL microcapsules is in the drug delivery field. 
Potential therapeutic biomolecules, such as DNA (Zelikin et al., 2006b, 2007) and insulin 
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(Ye et al., 2006), can be encapsulated and released for the possible treatment of diseases. 
An advantage of LbL microcapsule for drug delivery purposes over other conventional 
microcapsules is the variation of drug release mechanism that can be employed. By 
carefully selecting the type of polymers used during the LbL shell fabrication process, 
these LbL microcapsules can be designed such that the encapsulated biomolecules would 
be released when a change in the external environment pH (Ye et al., 2006), reducing 
conditions (Zelikin et al., 2006a) or in the presence of certain enzymes (Itoh et al., 2006)) 
occurs. For example, LbL polymer multilayers that are held together by disulfide covalent 
linkages could be easily disintegrated in the presence of a reducing agent (e.g. glutathione 
or dithiothreitol (DTT)), and thus releasing the encapsulated materials into the 
environment. A different approach for release of encapsulated DNA was recently 
demonstrated by Borodina et al. (2007). Rather than being subjected to external 
conditions, proteases were also encapsulated with the DNA that gradually broke down the 
poly(L-arginine)/poly(L-aspartic acid) LbL shell and released the encapsulated DNA. This 
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Chapter 3 – Objective & Specific Aims 
3.1 Objective 
The objective of this work is to perform and study the organic phase fabrication 
of core-shell materials for the encapsulation of biomolecules. 
 
3.2 Specific Aims 
To achieve the main objective of this project, there are five specific aims to be 
accomplished: 1) Fabrication of hydrogel microbeads as a core template and suitable 
vessel of biomolecules; 2) Selection of organic solvent and polymers for organic phase 
fabrication of core-shell materials; 3) Organic phase fabrication of hydrogel core-shell 
materials; 4) Characterization of fabricated core-shell materials 5) Encapsulation of 
macromolecular biomolecules within fabricated core-shell materials. 
 
3.2.1 Specific Aim 1 – Fabrication of Hydrogel Microbeads as a Core 
Template and Suitable Vessel of Biomolecules. 
The first specific aim entails the selection of the hydrogel to be used as the core 
template of the microcapsules and the means of fabricating the hydrogel into microbeads. 
The type of hydrogel and fabrication process should be simple and favorable for the pre-
loading and encapsulation of desired biomolecules. 
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3.2.2 Specific Aim 2 – Selection of Organic Solvent and Polymers for 
Organic Phase Fabrication of Core-Shell Materials 
Next, it is necessary to select an organic solvent for the organic phase fabrication of 
the core-shell materials. The organic solvent must be poorly miscible with water to 
minimize loss of pre-loaded biomolecules and is minimally hazardous to human health. 
Suitable polymers must also be identified with the following properties: i) soluble in the 
selected organic solvent, ii) able to interact with the core agarose microbeads via chemical 
means (e.g. electrostatic, hydrogen bonding, covalent bonding) for the formation of a 
stable “semi-permeable” polymeric membrane around each microbead and iii) possess 
hydrophilic properties as well (i.e. the polymer is amphiphilic in nature) such that 
aggregation of the hydrogel core-shell materials after transferring back into an aqueous 
phase can be prevented. 
 
3.2.3 Specific Aim 3 – Organic Phase Fabrication of Hydrogel Core-
Shell Materials 
A possible strategy for the organic phase fabrication of hydrogel microcapsules with 
polymeric shells is via the Reverse Phase-LbL (RP-LbL) technique. Depending on the 
interaction between the polymers and agarose microbeads, it might be necessary to 
consider additional chemicals that will be used for the formation of the “semi-permeable 
membranes”. For example, the type of cross-linkers to be used if the polymeric shell is to 
be formed around the agarose microbeads through covalent bonding. 
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3.2.4 Specific Aim 4 – Characterization of Fabricated Core-Shell 
Materials 
The resultant organic phase fabricated core-shell materials will be next characterized. 
In particular, it is important to demonstrate the formation of the shell as this is a 
component responsible for the encapsulation and retention of biomolecules within the 
core-shell materials. This demonstration will be performed with the use of fluorescence 
labeled polymers. Optical and confocal fluorescence microscopy will also be utilized to 
study the architecture of the fabricated core-shell materials. 
 
3.2.5 Specific Aim 5 – Encapsulation of Macromolecular Biomolecules 
within Fabricated Core-Shell Materials 
Lastly, macromolecular biomolecules will be encapsulated within the organic phase 
fabricated hydrogel core-shell materials. Various studies, such as retention efficiency and 
bio-functionality retention, will be performed on the resultant hydrogel core-shell 
materials containing the biomolecules to assess the possibility of applying these novel 
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Chapter 4 – Fabrication of Hydrogel Microbeads & 
Selection of Organic Solvent and Polymers for 
Fabrication of Polymeric Shells 
4.1 Introduction 
Encapsulation of biomolecules within microcapsules has been receiving tremendous 
attention over the recent years due to its application in many fields including bioreactors 
(Ghan et al., 2004; Lvov et al., 2001; Mak et al, 2008a), biosensors (Brown et al, 2005; 
Chinnayelka et al., 2005) and therapeutics (Ye et al., 2006; Zelikin et al., 2006b, 2007). 
The popularity of using microcapsules as an encapsulation vessel for biomolecules is due 
to theminute nature of microcapsules and thereby resulting in a high surface area to 
volume ratio that allows rapid exchange of materials with the environment. 
 
A popular technique to encapsulate biomolecules within microcapsules is through the use 
of the Layer-by-Layer (LbL) self-assembly of polymers technique (Decher, 1997). An 
approach to encapsulate biomolecules within LbL microcapsules involves the initial 
fabrication of hollow LbL microcapsules (Antipov et al., 2003b; Donath et al., 1998; 
Gittins and Caruso, 2000; Radtchenko et al., 2000). Next, the hollow microcapsules are 
immersed into a solution of the desired biomolecules where the biomolecules are driven 
by a concentration gradient and diffuse into the hollow LbL microcapsules (Gao et al., 
2002a, 2000b; Georgieva et al., 2002; Lvov et al., 2001). Alternatively, microcrystals of 
the desired biomolecules can be directly encapsulated using the LbL technique (Caruso et 
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al., 2000b; Trau and Renneberg, 2003) or via the Reverse-Phase LbL (RP-LbL) technique. 
The RP-LbL technique, for encapsulation of highly water soluble biomolecules 
microcrystals in the organic phase, had been recently introduced by our laboratory (Beyer 
et al., 2007). Since an organic phase was used, dissolution of the highly water soluble 
biomolecule microcrystals was not possible and hence these microcrystals could be used 
as templates. 
 
A third LbL approach is through pre-loading the desired biomolecules within a hydrogel 
core template prior to LbL polymer deposition treatment or termed as “matrix-assisted 
LbL encapsulation” technique. Using a hydrogel template has its advantages: i) the 
hydrogel can contain up to 98% of water and thereby providing a favorable environment 
for the encapsulated biomolecules, ii) the hydrogel matrix can act as a scaffold that 
provides mechanical support and maintains the spherical shape of the microcapsules, iii) 
the porous nature of hydrogel will permit unhindered diffusion of materials within and the 
template, and iv) fabrication of hydrogel microbeads via an emulsion technique can ensure 
that all starting materials are emulsified into the microbeads; resulting in known 
concentration(s) of pre-loaded biomolecule(s). However, the encapsulation of 
biomolecules via the “matrix-assisted LbL” approach results in significant loss of 
biomolecules during the fabrication of the LbL “semi-permeable” membrane (Mak et al., 
2008a) as an aqueous phase is used. 
 
To the best of our knowledge, there have been many works describing the encapsulation 
of biomolecules within microcapsules but few have described the organic phase 
fabrication of core-shell materials for the encapsulation of biomolecules. Encapsulation of 
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biomolecules in hydrogel core-shell materials fabricated in an organic phase possesses 
many advantages including good mechanical stability and a bio-friendly environment 
contributed by the agarose aqueous networked structure; and the possible high 
encapsulation efficiency of biomolecules due to the use of an organic solvent. In this 
chapter, the choice of agarose and water-in-oil emulsion technique as the hydrogel and 
microbead fabrication technique respectively will be discussed and demonstrated. An 
appropriate organic solvent and three possible polymers will be selected and discussed for 
the organic phase fabrication of the polymeric shell. Lastly, the fabricated hydrogel 
microbeads will be transferred to the organic solvent and the stability of these microbeads 
in the solvent will be presented and discussed. 
 
4.2 Materials and Methods 
Materials. 1-butanol anhydrous 99.8% and mineral oil were purchased from Sigma. 
Span
®
 80 was purchased from Fluka. Low-melting agarose was purchased from Promega. 
Ethanol was purchased from Fisher Scientific. All materials were used as received. 
Double distilled water (d.d H2O) used was distilled using a Fistreem™ Cyclone™ 
machine. 
 
Preparation of Agarose Microbeads A 2% w/v low-melting agarose in d.d H2O was 
prepared and kept molten at a temperature of 45 °C. The 2% agarose solution was then 
added to prewarmed mineral oil at 45 °C containing 0.1% Span
®
 80 (a non-ionized 
surfactant) and stirred vigorously for 10 minutes to form water-in-oil emulsion droplets. 
The droplets were then cooled in an ice water bath while stirring for another 10 minutes to 
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allow solidification of the molten agarose droplets into agarose microbeads. The solidified 
agarose microbeads were further stabilized by placing at -20 °C for 5 minutes. To transfer 
the agarose microbeads from mineral oil to 1-butanol, an equal amount of ethanol was 
added to the suspension and mixed vigorously followed by centrifugation (1000 rpm, 2 
minutes). Both mineral oil and ethanol were then discarded and the pellet containing the 
agarose microbeads was washed twice with 1-butanol by centrifugation (1000 rpm, 2 
minutes) and redispersion cycles. 
 
Optical Microscopy. Phase contrast microscopic images were recorded using a CCD 
color digital camera (Retiga 4000R, QImaging, Canada) connected to a system 
microscope (Olympus BX41, Japan). Images were captured with QCapture Pro software 
(Version 5.1.1.14, QImaging, Canada). 
 
4.3 Results and Discussion 
4.3.1 Selection and Fabrication of Hydrogel Microbeads as Core 
Templates 
 Hydrogels are composed of hydrophilic polymer networks that can absorb water with 
up to thousands of times of their dry weight (Hoffman, 2002). Calcium alginate and 
agarose are the commonest types of hydrogel microbeads used as these hydrogels are 
easily obtained from commercial sources and the process of converting these polymers 
into hydrogels is relatively simple. Gelation of calcium alginate is performed with 
multivalent ions of opposite charge while agarose is gelled by simply lowering the 
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temperature below its gelling temperature. Obtaining microbeads of calcium alginate or 
agarose can be achieved by water-in-oil emulsion technique. However, fabrication of 
calcium alginate microbeads having a homogenous gel network requires additional oil-
soluble organic acids (Reis et al, 2006). Since fabrication of agarose microbeads is a 
simpler process (lowering of temperature) when compared with fabrication of calcium 
alginate microbeads (requires multivalent ions and oil-soluble organic acids), the former 
was chosen as the core template. In addition, low melting agarose was chosen as a lower 
temperature is required to maintain this agarose in its molten state. This would thus allow 
for the encapsulation of temperature sensitive biomolecules. 
 
 
Scheme 4.1. Schematic diagram illustrating the fabrication of agarose microbeads using 
water-in-oil emulsion technique. 
 
   
 
Figure 4.1. Optical micrographs of (A) agarose microbeads dispersed in oil and (B) 
agarose microbeads dispersed in d.d H2O. The red boxes are included in (B) to aid in the 
identification of the agarose microbeads (whose properties are optically similar to that of 
the aqueous environment due to their high water content). 
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Scheme 4.1 shows the schematic fabrication of agarose microbeads via the water-in-oil 
emulsion technique (adopted from Mak et al., 2008b). Briefly, pre-warmed (45 °C) 
mineral oil containing SPAN
®
 80 (a non-ionic surfactant) and molten low melting agarose 
are mixed together. Next, the mixture is stirred continuously to emulsify the agarose into 
droplets. The droplets are subsequently cooled in an ice water bath to gel the agarose and 
thus forming the hydrogel microbeads. Optical micrographs of the agarose microbeads 
dispersed in oil (Figure 4.1A) and in water (Figure 4.1B) demonstrate that the fabricated 
microbeads are spherical in shape and have a wide size distribution. 
 
4.3.2 Selection of Suitable Organic Solvent and Polymers for Organic 
Phase Fabrication of Core-Shell Materials 
To prevent leakage of pre-loaded water-soluble biomolecules (i.e. allow high 
encapsulation) during the polymeric shell fabrication phase, 1-butanol was chosen as the 
organic phase solvent for polymers and dispersant for the hydrogel microbeads due to its 
low water solubility and minimal toxicity (when compared with other organic solvents 
such as chloroform, toluene and acetonitrile). 
 
Next, polymers had to be selected for the organic phase fabrication of core-shell materials. 
The polymers are required to be both soluble in 1-butanol and able to interact with the 
agarose templates to form the polymeric shells. Common polymers used in conventional 
aqueous phase LbL are poly(allylamine hydrochloride) (PAH), (poly (acrylic acid, sodium 
salt)) (PAA) and poly(sodium 4-styrene-sulphonate) (PSS); where PAH alone can also  
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Scheme 4.2. Non-ionized polymers that are soluble in 1-butanol and can be used for 
organic phase fabrication of hydrogel microcapsules with polymeric shells: (A) non-
ionized poly(allylamine) (B) non-ionized poly(acrylic acid) (C) non-ionized poly 
(styrenesulfonic acid). 
 
form polymeric shells through gluteraldehyde covalent cross-linking (Tong et al., 2006). 
The ionized forms of these polymers have very poor solubility in 1-butanol and therefore 
required treatment with acids/alkalis to form the non-ionized forms (Scheme 4.2) that 
allows its dissolution in 1-butanol. Commercially available non-ionized polymers could 
also dissolve in 1-butanol without the need for treatment. In both circumstances, the 
polymers could dissolve with a concentration of at least 1 mg mL
-1 
(a typical 
concentration for formation of LbL polymer multilayers (Peyratout, and Dähne, 2004)). 
NB: Only poly(allylamine) and poly(acrylic acid will be presented in subsequent chapters 
as only these 2 polymers were used. 
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4.3.3 Stability of Agarose Microbeads in 1-Butanol 
 
Figure 4.2. Optical micrograph of agarose microbeads aggregated and dehydrated in 1-
butanol. 
 
Agarose is hydrophilic when hydrated and hence microbeads fabricated from agarose 
can be stably dispersed in an aqueous solvent (Figure 4.1B). In contrast, these agarose 
microbeads do not disperse well in an anhydrous and hydrophobic solvent (1-butanol) but 
tend to shrink and aggregate (Figure 4.2). The aggregation observed is very likely caused 
by a polar-polar interaction between the agarose microbeads so as to minimize the 
interfacial surface area exposed to 1-butanol while the reduction in diameter is a result of 
dehydration by the anhydrous 1-butanol. Therefore, prior to fabricating hydrogel core-shell 
materials in 1-butanol, it is necessary to prevent the shrinkage and aggregation of agarose 
microbeads in 1-butanol. 
 
4.4 Conclusion 
In conclusion, low-melting agarose and a water-in-oil technique were selected as the 
hydrogel core and means of fabricating the hydrogel microbeads respectively. 1-butanol 
Chapter 4 – Fabrication of Hydrogel Microbeads & Selection of Solvent/Polymers 
 38
was selected as the organic solvent and three polymers (niPA, niPAA and niPSS) were 
identified that are soluble in 1-butanol and thus having the potential for organic phase 
fabrication of hydrogel core-shell materials. It was also demonstrated that agarose 
microbeads are unstable in 1-butanol and have a tendency to shrink and aggregate, thereby 
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Chapter 5 – Encapsulation of Biomolecules within 
Microparticles Stabilized Agarose Microbeads via the 
Reverse-Phase Layer-by-Layer Technique 
5.1 Introduction 
Surfactants, which possess an amphiphilic chemical structure, are commonly used in 
the preparation of emulsions. Other than these molecular surfactants, colloidal particles 
can also function like surfactants and be used in the preparation of emulsions; or better 
known as Pickering emulsions (Binks, 2002). The types of emulsions that can be prepared 
by these colloidal particles are dependent on the hydrophilicity or hydrophobicity of the 
microparticles. For hydrophilic particles, e.g. metal oxides, formation of oil-in-water 
emulsions are more likely to occur; while for hydrophobic particles, e.g. silica, formation 
of water-in-oil emulsions are more likely to occur. Due to this unique property of colloidal 
particles, colloidosomes have been fabricated through the self-assembly of microparticles 
onto the interface of emulsion droplets (Cayre et al., 2004; Hsu et al., 2005; Kim et al., 
2007). 
 
In this chapter, colloidal microparticles are utilized as surface stabilizers for the dispersion 
of agarose microbeads in 1-butanol. Once stabilized in 1-butanol, non-ionized 
polyallylamine (niPA) and non-ionized poly(acrylic acid) (niPAA) will be deposited onto 
these agarose microbeads via the RP-LbL technique. This would allow for the organic 
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Scheme 5.1. Schematic diagram illustrating the “matrix-assisted” colloidosome reverse-
phase Layer-by-Layer (MAC RP-LbL) microcapsules fabrication process. (Mak et al., 
2009, Reproduced by permission of American Chemical Society) 
 
phase fabrication of core-shell materials; where biomolecules or mixtures thereof can be 
preloaded and encapsulated within the hydrogel component. As an organic phase is used 
throughout the fabrication process, an encapsulation efficiency of almost 100% of the 
initial starting material is possible. The core-shell material preparation, termed as “Matrix 
Assisted” Colloidosome Reverse-Phase LbL (MAC RP-LbL), is illustrated in Scheme 5.1. 
In brief, a mixture of hydrogel (with biomolecules if desired) and microparticles is 
emulsified in oil at 45 °C to produce water-in-oil emulsion droplets with microparticles, 
which assemble at the hydrogel/oil interface, followed by cooling of the emulsion to 
solidify the droplets into hydrogel core templates with microparticles at the surface 
(matrix assisted colloidosomes or MACs). The MACs are then harvested from the 
emulsion, through washing with ethanol followed by dispersing in 1-butanol (organic 
phase). The MACs dispersed in 1-butanol are subsequently coated with non-ionized 
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polyelectrolytes (niPolyelectrolyte) niPA/niPAA multilayers using the RP-LbL technique 
to form core-shell materials. Finally, the core-shell materials are extracted from 1-butanol 
and re-dispersed in water. 
 
In this chapter, the importance of amino-PS microparticles for the stabilization of agarose 
microbeads in 1-butanol is shown. Next, the MAC (core) RP-LbL (shell) microcapsules 
are fabricated and the architecture is studied and discussed. Lastly, the feasibility of the 
MAC RP-LbL technique for the encapsulation of biomolecules such as bovine serum 
albumin (BSA), glucose oxidase (GOx) and horseradish peroxidase (HRP) is 
demonstrated. The encapsulation efficiency, retention stability and biological activity of 
encapsulated biomolecules within the resultant core-shell materials are also studied. 
 
5.2 Materials & Methods 
Materials. Poly(allylamine hydrochloride) (PAH) Mw 70,000 Da, poly(acrylic acid) 
(PAA) Mw 15,000 Da and poly(sodium 4-styrene-sulphonate) (PSS) Mw 70,000 Da were 
purchased from Aldrich. Glucose oxidase (GOx) from Aspergillus niger (156 U/mg), 
horseradish peroxidase (HRP) (181 U/mg), D-(+)-glucose, 98% sulphuric acid, 1-butanol 
anhydrous 99.8%, bovine serum albumin (BSA), mineral oil, N-(3-dimethylaminopropyl)-
N’-ethylcarbodiimide hydrochloride (EDC) and BSA-fluorescein isothiocyanate (BSA-
FITC) were purchased from Sigma. Span
®
 80, Rhodamine 123, N-hydroxysuccinimide 
(NHS), Ampliflu Red and sodium hydroxide (NaOH) were purchased from Fluka. Amino-
polystyrene (amino-PS) microparticles with diameter of 1.0 µm were purchased from 
Polysciences Inc. PS microparticles with diameter of 20 µm were purchased from 
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microParticles GmbH. Low melting agarose was purchased Promega. Ethanol was 
purchased from Fisher Scientific. Dimethyl sulfoxide (DMSO) was purchased from MP 
Biomedicals, Inc. PBS was purchased from 1
st
 BASE. All materials were used as received. 
Double distilled water (d.d H2O) used was distilled using a Fistreem™ Cyclone™ 
machine. 
 
Preparation of Matrix Assisted Colloidosomes (MACs). An aliquot of 500 µL amino-
PS microparticles from the stock solution was concentrated by centrifugation (4000 rpm, 6 
minutes) and the supernatant was subsequently removed. The amino-PS microparticles 
were re-dispersed in ethanol and washed under sonication for 30 minutes, followed by 
centrifugation (2000 rpm, 3 minutes) and removal of the supernatant. This washing 
procedure was repeated for 3 times. The microparticles were then dried, weighted, and re-
dispersed with d.d H2O to prepare a 20% w/v suspension. The microparticles were 
subsequently used for fabrication of MACs. For the preparation of biomolecule loaded 
MACs, amino-PS microparticles were blocked with 1% w/v BSA overnight to reduce 
non-specific adsorption of biomolecules onto the surface of the amino-PS microparticles. 
All necessary reagents were pre-warmed and kept at a temperature of 45 °C. A solution of 
4% w/v low-melting agarose was prepared and kept molten at a temperature of 45 °C. The 
molten agarose solution was then mixed with the amino-PS microparticles (20% w/v) and 
desired biomolecule solutions (e.g. BSA-FITC, GOx and HRP) to prepare a mixture with 
a final concentration of 2% w/v amino-PS microparticles in 2% w/v agarose containing 
the desired concentration of biomolecules. The agarose/amino-PS/biomolecules mixture 
was added to prewarmed mineral oil at 45 °C containing 0.1% Span 80 (a non-ionized 
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surfactant) and stirred vigorously for 15 minutes to form water-in-oil emulsion droplets 
stabilized by the microparticles assembled at the hydrogel/oil interface. The emulsion 
droplets were then cooled to 25 °C while stirring for another 10 minutes to allow 
solidification of the molten agarose core and formation of MACs. The MACs were further 
stabilized by placing at -20 °C for 5 minutes. 
 
Coating of MACs by Reverse-Phase LbL (RP-LbL). Non-ionized deprotonated PAH 
(niPA) solution was prepared by dissolving 1 g of PAH in 10 mL of d.d H2O and addition 
of 5 mL of 10 M NaOH solution, followed by vortexing with 1-butanol for 2 hours. 
Subsequently, the mixture was centrifuged (4000 rpm, 10 minutes) and the 1-butanol 
containing the niPA was extracted. An aliquot of 1 mL 1-butanol extract was dried, 
weighted and the amount of niPA was calculated. The extract was then diluted with 1-
butanol to prepare a 5 mg mL
-1
 niPA solution. Non-ionized protonated PAA (niPAA) 
solution was prepared by mixing 20 mL 35% w/v PAA with 5 mL 98% H2SO4 followed 
by vortexing with 1-butanol for 2 hours. Subsequently, the mixture was centrifuged (4000 
rpm, 10 minutes) and the 1-butanol containing the niPAA was extracted. The niPAA 
concentration was determined as described above for niPA and the extract was diluted 
with 1-butanol to prepare a 25 mg mL
-1
 niPAA solution. 
 
The RP-LbL coating process was entirely performed in 1-butanol with niPA and niPAA as 
niPolyelectrolytes. To transfer the MACs from mineral oil to 1-butanol, an equal amount 
of ethanol was added to the suspension and mixed vigorously, followed by centrifugation 
(1000 rpm, 2 minutes). The mineral oil and ethanol were then discarded and the pellet 
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containing the MACs was washed twice with 1-butanol by centrifugation (1000 rpm, 2 
minutes) and redispersion cycles. The resulting MACs were incubated with 1.5 mL of 
niPA for 15 minutes under gentle vortexing, followed by removal of the excess 
niPolyelectrolyte by three washing, centrifugation (1000 rpm, 2 minutes) and redispersion 
cycles with 1-butanol. The niPA coated MACs were overcoated with a second layer of 
niPAA using similar incubation, washing and redispersion procedures. Alternate 
deposition of niPA and niPAA was performed until the desired number of layers was 
achieved. The resulting RP-LbL coated MACs were washed twice with ethanol using 
similar centrifugation and re-dispersion procedures and finally re-dispersed in d.d H2O or 
buffer for storage. 
 
Preparation of Agarose Microbeads. Agarose microbeads were prepared with similar 
procedures as mentioned in the preparation of MACs except no amino-PS microparticles 
were used in the fabrication step. 
 
Coating of MACs and Agarose Microbeads by Aqueous-Phase LbL. MACs or agarose 
microbeads were transferred from mineral oil to PBS buffer by centrifugation (1000 rpm, 
2 minutes). The subsequent coating of the MACs or agarose microbeads was performed 
by using PAH (5 mg mL
-1
 in 0.01× PBS) and PSS (5 mg mL
-1
 in 1.5x PBS). Washing, 
centrifugation and re-dispersion cycles with 0.01× PBS buffer was similarly performed as 
described above for the RP-LbL coating. 
 
Characterization of Non-ionized Polyelectrolyte (niPolyelectrolyte) Multilayer 
Coating. A PAA-Rhodamine 123 conjugate was synthesized based on EDC/NHS 
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chemistry. The carboxyl group of PAA was activated by addition of excess EDC and NHS 
for 15 minutes. Rhodamine 123 dissolved in DMSO was mixed with the activated PAA at 
a molar ratio of 1:10 (Rhodamine 123 molecule:PAA monomer) and incubated for 12 
hours at 25 °C. The PAA-Rhodamine 123 conjugate was purified by dialysis (molecular 
weight cut-off of 3.5 kDa) and dried. niPAA-Rhodamine 123 (niPAA-Rho123) was 
prepared with similar procedures as mentioned for the preparation of niPAA. For the 
demonstration of multilayer deposition, niPA and a mixture of niPAA and niPAA-Rho123 
(9:1) was used to coat the 20 µm PS microparticles and MACs. The resulting core-shell 
materials were examined by fluorescence microscopy. 
 
Zeta Potential Measurements. All zeta potential measurements were performed after 
transferring the PS microparticles from 1-butanol to 0.01x PBS. The zeta potential values 
were obtained by measuring the electrophoretic mobility of the microparticles using a 
microelectrophoresis machine (Zeta Sizer Nano, Malvern, United Kingdom). 
 
Biological Activity Study. 7 layers of niPolyelectrolyte coated MAC RP-LbL 
microcapsules, that contain 2.34 U GOx and 2.715 U HRP as the initial enzyme loading 
quantity, were fabricated with similar procedures as mentioned above. The resulting 
microcapsules were incubated with 0.5x PBS buffer (pH 7.4) and allowed to stand for 90 
minutes for stabilization. The enzymatic activity of the encapsulated enzymes within the 
MAC RP-LbL microcapsules was compared with a bulk phase enzyme solution 
containing the same amount of enzymes. A solution mixture containing 2.84 mL of 1x 
PBS (pH 7.4), 1 mL of 5 mg mL
-1
 glucose in 1x PBS and 10 µl of 5 mg mL
-1
 Ampliflu 
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Red in DMSO were continuously shaken with either 150 µl of MAC RP-LbL 
microcapsules or an enzyme solution that contains the same enzyme concentrations. The 
enzymatic reaction of the reaction mixtures were determined by measuring the absorbance 
of the reaction mixture at 571 nm with a UV-VIS spectrophotometer (UV-2450, Shimadzu 
Corp., Japan). 
 
Optical and Fluorescence Microscopy. Phase contrast and fluorescence microscopic 
images were recorded using a CCD color digital camera (Retiga 4000R, QImaging, 
Canada) connected to a system microscope (Olympus BX41, Japan) with a mercury arc 
(Olympus HBO103W/2, Japan) excitation source. Bandpass filters with excitation 
wavelength of 488 nm and emission wavelength of 520 nm were used for FITC and 
Rhodamine 123 detection. Images were captured with QCapture Pro software (Version 
5.1.1.14, QImaging, Canada) and analyzed by QCapture Pro software or ImageJ software 
(Scion Corp., USA). Stereo microscopic images were acquired using a CCD color camera, 
(Evolution™ MP, MediaCybernatics, USA) connected to a stereo microscope (Axiostar 
plus, Carl Zeiss GmbH, Germany). Confocal fluorescence microscopic images were 
captured using a laser scanning confocal microscope (Leica TCS SP2, Leica Microsystem 
Heidelberg GmbH, Germany). 
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5.3 Results & Discussion 
5.3.1 Morphology and Stability of “Matrix-Assisted” Colloidosomes 
(MACs) in 1-Butanol  
In Chapter 4, it was demonstrated that the dispersion of hydrophilic agarose 
microbeads in a hydrophobic organic phase (1-butanol) is difficult as agarose microbeads 
in 1-butanol aggregate severely with a concomitant reduction in diameter. In order to 
stabilize the agarose microbeads in organic phase, microparticles were introduced into the 
agarose microbead fabrication process to produce “matrix-assisted” colloidosomes 
(MACs).  
 
Figure 5.1. (A) Optical transmission micrograph of MACs dispersed in 1-butanol with 
good colloidal stability. (B) Confocal fluorescence micrograph of MACs fabricated with 
BSA-FITC tagged amino-PS microparticles. A fluorescence ring is observed around the 
MACs surface. (C) High magnification micrograph of MACs obtained via reflection mode 
and showing the assembled-microparticles distributed on the surface of an agarose 
microbeads. (Mak et al., 2009, Reproduced by permission of American Chemical Society) 
 
During fabrication of MACs through an emulsification process, the microparticles would 
migrate and self-assemble at the interfaces of the water-in-oil emulsion droplets (agarose 
droplet surfaces) so as to minimize the total interfacial energy (Cayre et al., 2004; Lin et 
al., 2003).  
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The resulting MACs were transferred and dispersed in 1-butanol where the morphology 
and stability of these MACs were examined with transmission phase contrast, reflection 
and confocal optical microscopy. The phase contrast micrograph (Figure 5.1A) shows 
MACs in 1-butanol having spherical shapes and exhibiting no significant aggregation. The 
confocal micrograph (Figure 5.1B) depicts MACs, fabricated with BSA-FITC tagged 
microparticles, having a fluorescence ring around each MAC; indicating a large 
population of microparticles lining up on the surface of each MAC. A high magnification 
micrograph obtained via reflection mode shows assembled microparticles distributed on 
the surface of an agarose microbead (Figure 5.1C). From these results, it is demonstrated 
that the microparticles had assembled around the surface of each agarose microbead and 
stabilized the agarose core templatess in 1-butanol. This stabilization is believed to have 
been contributed by the reduction of interfacial surface area between the hydrophilic 
 
Figure 5.2. Size distribution of (A) MACs (n = 2000 for either dispersant) and (B) 
agarose microbeads (n = 2000 for either dispersant) dispersed in 1-butanol (shaded 
column) and dispersed in d.d. H2O (blank column). Only microbeads with diameters > 10 
µm were considered. (p value = 1 for a 2-tailed t-test based on size range). MACs 
dispersed in 1-butanol and d.d. H2O show similar size distribution, while agarose 
microbeads show a significant shift in size distribution to a smaller diameter range when 
dispersed in 1-butanol. (Mak et al., 2009, Reproduced by permission of American 
Chemical Society) 
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agarose core and the 1-butanol. Besides morphology, the size distribution of MACs 
dispersed in organic phase (1-butanol) and aqueous phase (d.d H2O) were compared to 
determine if shrinking of MACs in 1-butanol had occured. Figure 5.2A shows no 
significant changes in the size distribution of MACs from the same preparation batch in 
either dispersant. Assuming MACs in aqueous phase to possess the highest degree of 
hydration (i.e. no shrinkage), the insignificant differences in size distribution indicates that 
there was insignificant shrinkage of MACs when dispersed in 1-butanol. On the contrary, 
agarose microbeads from the same preparation batch show a significant shift in size 
distribution to a smaller diameter range when dispersed in 1-butanol (Figure 5.2B). Both 
size distributions of MACs and agarose microbeads were obtained immediately after 
dispersing in their respective solvents. The reduction in direct surface area exposure of the 
agarose beads to 1-butanol is believed to have slowed down the process of dehydration 
and therefore no immediate shrinking of the hydrogel core was observed. These results 
indicate that microparticles are important in stabilizing the agarose core in 1-butanol and 
MACs are stable in 1-butanol for subsequent RP-LbL deposition of polymers. 
 
5.3.2 Importance of an Organic Phase to Prevent Leaching of Pre-
Loaded Biomolecules from MACs  
In order to achieve a high encapsulation efficiency of biomolecules, pre-loaded 
biomolecules have to be prevented from leaching out of the hydrogel core during 
fabrication of the polymeric “semi-permeable membrane” shell. No significant leaching of 
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Figure 5.3. (A) Relative fluorescence intensity of MACs loaded with BSA-FITC 
dispersed in 1-butanol (circle) and d.d. H2O (triangle) over a 5 day period. The 0
th
 day 
represents the freshly fabricated MACs dispersed in 1-butanol. (B) Phase contrast and 
corresponding fluorescence micrographs of MACs after 5 days incubation in 1-butanol or 
d.d. H2O. (Mak et al., 2009, Reproduced by permission of American Chemical Society) 
 
biomolecules can occur during the water-in-oil emulsion step as most biomolecules are 
poorly soluble in oil. However, leaching of biomolecules can occur during dispersion of 
MACs in aqueous phase for traditional LbL coating. The applicability of 1-butanol as 
dispersant to prevent leaching of water soluble biomolecules from MACs was studied by 
using BSA- FITC as a model material. The fluorescence intensity of BSA-FITC retained 
within individual MACs compared to the initial fluorescence intensity represents the 
relative entrapment efficiency. The initial fluorescence intensity of MACs in 1-butanol at 
0
th
 day was normalized to 100% for data comparison. MACs loaded with 0.125 mg mL
-1 
BSA-FITC were fabricated and transferred to either 1-butanol or d.d H2O. The resulting 
MACs were incubated for a period of 5 days and the fluorescence content within the 
MACs was measured. Figure 5.3A shows that no significant leakage of BSA-FITC was 
observed when the MACs were dispersed in 1-butanol during the entire incubation period, 
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while almost 100% of BSA-FITC leached out immediately from the MACs when 
dispersed in d.d H2O. The entrapment efficiency of BSA-FITC loaded MACs in 1-butanol 
was about 97%. Figure 5.3B shows the phase contrast and the corresponding fluorescence 
micrographs of MACs after 5 days incubation in 1-butanol or d.d H2O. Fluorescence 
signal emitted from BSA-FITC was observed in MACs incubated in 1-butanol, while 
insignificant fluorescence signal was observed from MACs incubated in d.d. H2O. This 
result clearly demonstrates that 1-butanol is a suitable organic phase for fabrication of 
core-shell materials as it minimizes loss of pre-loaded biomolecules from within the 
MACs. Surprisingly, no significant shrinking of the MACs could be observed after 5 days 
of incubation in 1-butanol; this further emphasizes on the importance of using 
microparicles as stabilizers of agarose microbeads in 1-butanol.  
5.3.3 Demonstration of Organic Phase Fabrication of Non-Ionized 
Polyelectrolyte (niPolyelectrolyte) Multilayer Shell onto PS 
Microparticles via the RP-LbL Technique  
 
Figure 5.4. (A) Fluorescence intensity (pixel value) of 20 µm PS microparticles coated 
with n(niPA/niPAA-Rho123) as a function of layer number. (B) Zeta potential as a 
function of layer number (No) for coating of niPA and niPAA onto PS microparticles via 
the RP-LbL technique 
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To study the deposition of niPA and niPAA via the RP-LbL technique for the fabrication 
of polymeric shells, niPAA-Rho123 was used to coat 20 µm PS microparticles. niPA was 
coated as the odd layers while niPAA-Rho123 was coated as the even layers. Figure 5.4A 
shows the fluorescence intensity of PS microparticles as a function of the number of 
coated layers. The fluorescence intensity of PS microparticles after each layer coating was 
quantified by capturing the fluorescence image of the microparticles and measuring the 
pixel values of each image using ImageJ. It was noted that the fluorescence intensity of 
the microparticles increases after each bi-layer coating and this increase in fluorescence 
intensity is contributed from the accumulation of niPAA-Rhodamine 123 onto the 
microparticles after each even coating. This result demonstrates that niPA and niPAA can 
be stepwise coated onto PS microparticles by the RP-LbL technique to form polymeric 
shells. As further evidence for coating of niPA and niPAA onto the PS microparticles via 
the RP-LbL technique, the zeta-potential of the microparticles after each layer coating was 
measured. Figure 5.4B shows the zeta potential of the PS microparticles after coating of 
each layer. The alternating magnitudes of the zeta potential from initially -30 mV (zeta 
potential of “bare” PS microparticles) to +7, +11 and +12 mV for deposition of niPA 
layers and -50, -44 and -62 mV for deposition niPAA layers provides added evidence for 
coating of niPA and niPAA onto a template via the RP-LbL technique to form polymeric 
shells. 
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5.3.4 Demonstration of Organic Phase Fabrication of Non-Ionized 
Polyelectrolyte (niPolyelectrolyte) Multilayer Shell onto MACs via the 
RP-LbL Technique  
 
Figure 5.5. Fluorescence intensity (pixel value) of MACs coated with n(niPA/niPAA-
Rho123) as a function of layer number. (Mak et al., 2009, Reproduced by permission of 
American Chemical Society) 
 
The organic phase fabrication of polymeric shells onto MACs by the RP-LbL technique 
using 1-butanol was studied with deposition of niPAA-Rho123. The fluorescence intensity 
of MACs after each bi-layer coating [niPAH/ niPAA-Rho123] was measured by analyzing 
the fluorescence micrographs of MACs based on densitometry and represented by pixel 
values. The fluorescence intensity of MACs as a function of the number of bi-layers was 
plotted in Figure 5.4 and it clearly shows the increment in fluorescence intensity of MACs 
when the number of bi-layer coatings increases. The increase in fluorescence intensity is 
due to an accumulation of niPAA-Rho123 onto the MACs after each bi-layer coating. This 
result demonstrates that stepwise RP-LbL self-assembly of niPolyelectrolyte layers onto 
MACs for polymeric shell fabrication in 1-butanol is possible. 
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5.3.5 Retention of Biomolecules within MAC RP-LbL Hydrogel 
Microcapsules  
 
Figure 5.6. The relative retention efficiency of MAC RP-LbL microcapsules with 7 layers 
of niPolyelectrolyte (circle) and MACs with no layers (triangle) in d.d. H2O over a period 
of 7 days. The 0
th
 day represents fluorescence intensity measured immediately after 
transferring the samples from 1-butanol to d.d. H2O and MAC RP-LbL microcapsules at 
0
th
 day were taken as 100%. (Mak et al., 2009, Reproduced by permission of American 
Chemical Society) 
 
As most biochemical reactions take place in an aqueous environment, it is therefore 
necessary to determine whether the resulting MAC RP-LbL microcapsules can retain their 
biomolecule contents when dispersed in an aqueous environment. The retention of 
biomolecules within MAC RP-LbL microcapsules was studied by using BSA-FITC filled 
MAC RP-LbL microcapsules. MACs containing 0.125 mg mL
-1
 BSA-FITC were coated 
with 7 niPolyelectrolyte layers and transferred from 1-butanol to d.d. H2O followed by an 
incubation of 7 days. In order to demonstrate the importance of the polymeric shell 
“membrane” for retention of biomolecules within MAC RP-LbL microcapsules, MACs 
containing 0.125 mg mL
-1
 BSA-FITC without LbL coating (i.e. no shell “membrane”) 
were used as a control experiment. 
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The retention efficiency of BSA-FITC as a function of time is shown in Figure 5.5. The 0
th
 
day represents the fluorescence intensity measured immediately after transferring the 
samples from 1-butanol to d.d. H2O and the fluorescence intensity of MACs at 0
th
 day is 
normalized to 100% retention efficiency. The fluorescence intensity measured within 
individual microcapsules, after dispersion in water and compared to the fluorescence 
intensity of MACs at 0
th
 day, reflects the relative retention efficiency. MAC RP-LbL 
microcapsules retained ~100% of BSA-FITC after 7 days of incubation, while MACs 
without LbL coating immediately released more than 90% of the BSA-FITC after 
dispersion in d.d. H2O. This result demonstrates that the retention of biomolecules 
depends on the formation of the polymeric shell with sufficiently small pore size (i.e. the 
pore size of the shell is small enough to prevent out-diffusion of the large molecular 
weight biomolecules from the hydrogel core to the outer environment.) 
 
5.3.6 Significances of MACs and the RP-LbL Technique to Achieve 
High Encapsulation Efficiency of Biomolecules 
The ability of the MAC RP-LbL encapsulation technique to achieve extremely high 
encapsulation efficiency of biomolecules arises from using the RP-LbL technique to 
perform polymeric shell fabrication in an organic phase and thereby preventing the out 
diffusion of pre-loaded highly water soluble materials from the core. 
 
In order to emphasis on the unique advantages of the MAC RP-LbL technique, the 
encapsulation efficiency of MAC RP-LbL microcapsules were compared with those of  
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Figure 5.7. Relative encapsulation efficiency of microcapsules prepared from MACs with 
7 layers of RP-LbL coating, MACs with 7 layers of Aq-LbL coating, Agarose microbeads 
with 7 layers of Aq-LbL coating and MACs without any LbL coating (control). (Mak et 
al., 2009, Reproduced by permission of American Chemical Society) 
 
microcapsules fabricated with traditional aqueous LbL (Aq-LbL) using PAH/PSS as 
polyelectrolytes and MACs or agarose microbeads as core template. MACs containing 
0.125 mg mL
-1
 BSA-FITC were coated with 7 layers of niPolyelectrolyte using RP-LbL, 
while MACs or agarose microbeads containing 0.125 mg mL
-1
 BSA-FITC were coated 
with 7 layers of polyelectrolyte using Aq-LbL. MACs containing 0.125 mg mL
-1
 BSA-
FITC without any polymeric shells were used as a control. Figure 5.6 shows the relative 
encapsulation efficiencies (calculated from fluorescence intensities of BSA-FITC) of 
microcapsules fabricated with MAC RP-LbL, MAC Aq-LbL, agarose Aq-LbL and control 
MAC without LbL coating were 100%, 51.2%, 9.4% and 2.5% respectively. This result 
demonstrates that the MAC RP-LbL microcapsules have an encapsulation efficiency that 
is 10 times (i.e. achieved 100% encapsulation efficiency) better than the encapsulation 
efficiency of agarose Aq-LbL microcapsules. Interestingly, MAC Aq-LbL microcapsules 
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demonstrated an encapsulation efficiency that is 5 times higher than that of agarose Aq-
LbL microcapsules. This 5 fold increment in encapsulation efficiency can be attributed to 
the microparticles assembled on the surface of agarose microbeads. By assembling 
microparticles onto the surface of each agarose microbead, the microparticles reduce the 
interfacial surface area between each agarose microbead and the aqueous environment, 
and effectively hinder the out diffusion of biomolecules from the core. This result 
demonstrates that the organic phase fabrication MAC RP-LbL microcapsules is an ideal 
approach for encapsulating water soluble biomolecules with extremely high encapsulation 
efficiency. 
 
5.3.7 Biological Activity of Encapsulated Biomolecules within MAC 
RP-LbL Microcapsules  
Besides the encapsulation and retention efficiency, the feasibility of the MAC RP-LbL 
method to encapsulate a mixture of biomolecules and to preserve their biological activity 
was studied. A bienzyme system using glucose oxidase (GOx) and horseradish peroxidase 
(HRP) was used as a model. GOx converts glucose in the presence of oxygen into 
gluconolactone and hydrogen peroxide, and HRP utilizes the generated hydrogen peroxide 
to oxidize Ampliflu Red into a red color product with an absorbance at 571 nm. MAC RP-
LbL microcapsules coated with 7 niPolyelectrolyte multilayers and using 15.6 mU µL
-1
 
GOx and 18.1 mU µL
-1
 HRP as initial starting materials were prepared. The enzymatic 
activity of the enzymes encapsulated within the MAC RP-LbL microcapsules was 
compared with a bulk phase enzyme solution containing the same amount of  
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Figure 5.8. Enzymatic reaction of free enzymes in solution (triangle) and enzymes 
encapsulated within MAC RP-LbL microcapsules (square). (Mak et al., 2009, Reproduced 
by permission of American Chemical Society) 
 
enzymes. Figure 5.7 shows the normalized absorption at 571 nm as a function of time. The 
slope of each data plot was calculated via linear regression analysis and represents the rate 
of the enzymatic reaction. Result shows that the reaction rates of the encapsulated 
enzymes within the MAC RP-LbL microcapsules and those of the free enzymes in bulk 
phase were 0.023 (absorbance minutes
-1




The significant decrease in enzymatic reaction rate of the MAC RP-LbL microcapsules 
can be attributed to the different types of diffusion barriers created by the assembled 
amino-PS microparticle, the agarose core matrix and the polymeric RP-LbL shell; where 
the microparticle barrier is the most likely cause for the reduced enzymatic reaction rate. 
In the bienzyme system, the large molecular weight GOx (~160 kDa) and HRP (~44 kDa) 
remain encapsulated inside the MAC RP-LbL microcapsules, whereas the small molecular 
weight glucose (180 g mol
-1
) and Ampliflu Red (257.2 g mol
-1
) are required to diffuse 
through the diffusion barriers for the colorimetric assay to take place. Among all three 
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diffusion barriers, the agarose core matrix and the polymeric RP-LbL shell remain 
permeable to small molecular weight substrate molecules. In contrast, the amino-PS 
microparticles are impermeable to the substrate molecules and diffusion is only allowed 
through the gaps between assembled microparticles. Since, the amino-PS microparticles 
cover a high percentage of the total effective surface area (Figure 5.1C) of the MAC RP-
LbL microcapsules, it is suggested that the slow enzymatic reaction rate observed is 
mainly due to the diffusion barrier created by the assembled amino-PS microparticles. 
 
5.4 Conclusion 
The stable dispersion of hydrogel microbeads in 1-butanol was demonstrated through 
the creation of MACs with amino-PS microparticles as surface stabilizer. The 
microparticles reduce exposure of the hydrogel surface to the organic phase and thus 
prevented the hydrogel microbeads from aggregation and shrinkage. Following, organic 
phase fabrication of core-shell materials was achieved via the deposition of niPA and 
niPAA onto the MACs via the RP-LbL technique; where the MACs formed the core 
template and the self-assembled niPA and niPAA formed the shell. MAC RP-LbL 
microcapsules, pre-loaded with biomolecules, demonstrated high encapsulation efficiency 
and excellent retention stability. BSA-FITC with a molecular weight of ~65,000 Da was 
used as a model protein for the encapsulation and retention study. A high encapsulation 
efficiency and retention stability of almost 100% of the initial loaded biomolecules was 
achieved by using the MAC RP-LbL core-shell fabrication technique. The ability of MAC 
RP-LbL technique to achieve high encapsulation efficiency is a result of using the RP-
LbL technique to fabricate the polymeric shells, thus minimizing the out diffusion and loss 
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of pre-loaded highly water soluble biomolecules from the hydrogel core. The high 
encapsulation efficiency achieved using this technique is especially useful for the 
encapsulation of scarce, valuable and expensive proteins. Limitations of this method are 
the loading density (which is limited by solubility of the biomolecules in agarose) and the 
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Chapter 6 – Encapsulation of Biomolecules within 
ADOGEN
®
 464 Stabilized Agarose Microbeads via the 
Reverse-Phase Layer-by-Layer Technique 
6.1 Introduction 
In Chapter 5, organic phase fabrication of core-shell materials and encapsulation of 
biomolecules was successfully carried via the fabrication of “matrix-assisted” 
colloidosome Reverse-Phase LbL (MAC RP-LbL) microcapsules; where amino-PS 
microparticles were used to confer stability and to disperse the agarose microbeads in 1-
butanol. Previously, it had been demonstrated that alginate microbeads could be stabilized 
and dispersed in alcohols with the use of cationic surfactants (Doumèche et al., 2002). In 
this chapter, the agarose microbeads are stabilized in 1-butanol with the use of ADOGEN
®
 
464, a cationic surfactant, instead of using amino-PS microparticles. The use of a cationic 
surfactant further simplifies the microcapsule fabrication procedure and makes the 
procedure more cost effective. The resultant core-shell materials, without the 
microparticles, might become more suitable for in-vivo experiments. Following, the 
stabilized agarose core templates in 1-butanol are coated with non-ionized polyelectrolytes 
(niPolyelectrolytes) poly(allylamine) (niPA) and poly(acrylic acid) (niPAA) for the 
fabrication of the LbL polymeric shells. The microcapsule fabrication process is similar to 
the fabrication of MAC RP-LbL microcapsules except no amino-PS microparticles were 
used and ADOGEN
®
 464 is used to confer stability to the agarose microbeads in 1-butanol  
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Scheme 6.1. Schematic diagram illustrating the transfer of agarose core templates into 1-
butanol using ADOGEN
®
 464 following by fabrication of the LbL polymeric shells via 
the RP-LbL technique. 
 
instead (Scheme 6.1). Briefly, agarose droplets (containing pre-loaded biomolecules) are 
first fabricated via water-in-oil emulsion. Next, these droplets are cooled to gel the agarose 
and thus forming agarose microbeads. The microbeads are then transferred into ethanol 
containing ADOGEN
®
 464 before transferring into 1-butanol containing ADOGEN
®
 464. 
Non-ionized polyelectrolytes (niPolyelectrolytes) are next deposited onto the surfaces of 
these agarose core templates dispersed in 1-butanol for the organic phase fabrication of 
core-shell materials. 
 
In Chapter 6, the stability of these agarose microbeads in 1-butanol conferred via the use 
of ADOGEN
®
 464, and the coating of niPolyelectrolytes onto these agarose microbeads 
are demonstrated and discussed. Lastly, the retention efficiency of dextran molecules of 
different molecular weight within these core-shell materials is studied and discussed. 
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6.2 Materials & Methods 
Materials Dextran-TRITC Mw 65,000-76,000 Da, dextran-TRITC Mw 155,000 Da, 
dextran-FITC Mw 2,000,000 Da, 1-butanol anhydrous 99.8%, mineral oil and N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) were purchased from 
Sigma. Dextran-FITC Mw 500,000 Da, Span
®
 80, Rhodamine 123 and N-
hydroxysuccinimide (NHS) were purchased from Fluka. Poly(allylamine) (PA) Mw 65,000 
Da and poly(acrylic acid) (PAA) Mw 450,000 Da, ADOGEN
®
 464 were purchased from 
Aldrich. Low melting agarose was purchased from Promega. Ethanol was purchased from 
Fisher Scientific. Dimethyl sulfoxide (DMSO) was purchased from MP Biomedicals, Inc. 
PBS and TRIS buffer (pH~8) were purchased from 1
st
 BASE. All materials were used as 
received. Double distilled water (d.d H2O) used was distilled using a Fistreem™ 
Cyclone™ machine. 
 
Preparation of Agarose Microbeads with Pre-Loaded Dextran An 8% w/v low-
melting agarose in d.d H2O was prepared and kept molten at a temperature of 45 °C. The 
molten agarose was then mixed with the dextran of desired molecular weight to prepare a 
mixture with a final concentration of 2% w/v agarose containing 1 mg mL
-1
 of dextran. 
All reagents were prewarmed and kept at a temperature of 45 °C. The agarose mixture was 
added to prewarmed mineral oil at 45 °C containing 0.1% Span 80 (a non-ionized 
surfactant) and stirred vigorously for 10 minutes to form water-in-oil emulsion droplets. 
The droplets were then cooled in an ice water bath while stirring for another 10 minutes to 
allow solidification of the molten agarose droplets into agarose microbeads. The solidified 
agarose microbeads were further stabilized by placing at -20 °C for 5 minutes. 
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Coating of Non-ionized Polyelectrolytes (niPolyelectrolytes) onto Agarose 
Microbeads by Reverse-Phase LbL (RP-LbL) Non-ionized deprotonated 
poly(allylamine) (niPA) solution was prepared by aliquoting PA from the stock solution, 
drying for 2 days at 80 °C and fully saturating 1-butanol with the dried PA. The saturated 
1-butanol containing the niPA was extracted and 1 mL of the 1-butanol extract was dried 
and weighed; and the amount of deprotonated PA was calculated. The 1-butanol extract 
was then diluted with 1-butanol containing 0.5% ADOGEN
®
 464 to prepare a 1 mg mL
-1
 
niPA solution. Non-ionized protonated poly(acrylic acid) (niPAA) solution was prepared 
by dissolving PAA in 1-butanol 0.5% ADOGEN
®




The RP-LbL coating process was entirely performed in 1-butanol with niPA and niPAA as 
niPolyelectrolytes. To transfer the agarose microbeads suspension from mineral oil to 1-
butanol, 2 mL of ethanol containing 0.5% ADOGEN
®
 464 was added to the suspension 
and mixed vigorously, followed by centrifugation (1000 rpm, 1 minute). The mineral oil 
and ethanol supernatant was then discarded and the pellet containing the agarose 
microbeads was washed twice with 1.5 mL of 1-butanol containing 0.5% ADOGEN
®
 464 
by centrifugation (1000 rpm, 1 minute) and redispersion cycles. The resulting agarose 
microbeads were then incubated with 1.5 mL of niPA for 15 minutes under gentle 
vortexing, followed by removal of the excess niPolyelectrolyte by two washing, 
centrifugation (500 rpm, 30 seconds) and redispersion cycles with 1-butanol. The niPA 
coated agarose microbeads were overcoated with a second layer of niPAA using similar 
incubation, washing and redispersion procedures. Alternate deposition of niPA and niPAA 
was performed until the desired number of layers was achieved. The resulting LbL 
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encapsulated agarose microbeads were then washed twice with ethanol using 
centrifugation (800 rpm, 30 seconds) and re-dispersion procedures.  
 
To transfer the polymer coated agarose microbeads from ethanol into 0.01× PBS, a 
stepwise approach using decreasing ratios of ethanol: 5 mg mL
-1
 PAH in 0.05x PBS were 
used. The polymer coated agarose microbeads in ethanol were first dispersed in (90% 
ethanol and 10% 5 mg mL
-1
 PAH in 0.05x PBS) followed by (50% ethanol and 50% 5 mg 
mL
-1
 PAH in 0.05x PBS) using centrifugation and redispersion procedures (800 rpm, 30 
seconds). Finally, the resultant polymer coated agarose microbeads were transferred into 
0.01× PBS. 
 
Size Distribution Determination of Agarose Microbeads in 1-Butanol Containing 
ADOGEN
®
 464 and in d.d H2O 2% agarose microbeads, from the same fabrication batch, 
were dispersed in either 1-butanol containing ADOGEN
®
 464 or in d.d H2O. Random 
phase contrast images of the agarose microbeads in both dispersant were subsequently 
obtained and the diameters of the imaged agarose microbeads were measured by QCapture 
Pro software (Version 5.1.1.14, QImaging, Canada). 
 
Demonstration of Non-ionized Polyelectrolyte (niPolyelectrolyte) Coating onto 
Agarose Microbead by the RP-LbL Technique A PAA-Rhodamine 123 conjugate was 
synthesized based on EDC/NHS chemistry. The carboxyl group of PAA was activated by 
addition of excess EDC and NHS for 15 minutes. Rhodamine 123 dissolved in DMSO 
was mixed with the activated PAA at a molar ratio of 1:10 (Rhodamine 123 molecule: 
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PAA monomer) and incubated for 12 hours at 25 °C. The PAA-Rhodamine 123 conjugate 
was purified by dialysis (molecular weight cutoff of 5,000-8,000 Da) against d.d H2O for 
3 days and dried. The dried PAA-Rhodamine 123 conjugate was then weighed and finally 
dissolved in 1-butanol to form a 0.5 mgmL
-1
 PAA-Rhodamine 123 solution. For the 
demonstration of multilayer deposition, niPA and a mixture of niPAA and niPAA-Rho123 
(9:1) were used to coat the agarose microbeads. The resulting LbL microcapsules were 
examined by fluorescence microscopy. 
 
Optical and Fluorescence Microscopy Phase contrast and fluorescence microscopic 
images were recorded using a CCD color digital camera (Retiga 4000R, QImaging, 
Canada) connected to a system microscope (Olympus BX41, Japan) with a mercury arc 
(Olympus HBO103W/2, Japan) excitation source. Bandpass filters with λex 488 nm and 
λem 520 nm were used for Rhodamine 123 and FITC detection while bandpass filters with 
λex 560 nm and λem 630 nm were used for TRITC detection. Images were captured with 
QCapture Pro software (Version 5.1.1.14, QImaging, Canada) and analyzed by ImageJ 
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6.3 Results & Discussion 
6.3.1 Morphology and Stability of ADOGEN® 464 Stabilized Agarose 
Microbeads in 1-Butanol  
 
 
Figure 6.1. Optical micrograph of agarose microbeads dispersed in 1-butanol with the use 
of ADOGEN
®
 464. Red boxes are included to aid in the identification of the microbeads.  
 
As demonstrated in Chapter 4 (Figure 4.2), agarose microbeads do not disperse well in 
1-butanol but tend to aggregate and shrink when transferred into 1-butanol; and it was 
demonstrated that through the use of amino-PS microparticles, these agarose microbeads 
could be dispersed in 1-butanol. Here, a cationic surfactant ADOGEN
®
 464 was used to 
stabilize the agarose microbeads and it can also be observed that the agarose microbeads 
did not aggregate but dispersed well in 1-butanol (Figure 6.1). Other types of surfactants, 
such as Triton
®
 X-100 (non-ionic surfactant) and sodium dodecyl sulfate (anionic 
surfactant), were also used but could not stabilize agarose microbeads in 1-butanol (data 
not shown). No significant differences were observed between the size distributions of  
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Figure 6.2. Size distribution of agarose microbeads (n = 2000 for either dispersant) 
dispersed in d.d H2O (blank column) and in 1-butanol containing ADOGEN
®
 464 (shaded 
column). Only microbeads with diameters > 10 µm were considered (p = 1 for a two-
tailed t test based on size range). No significant differences in size distribution are 
observed. 
 
agarose microbeads dispersed in d.d H2O or in 1-butanol containing ADOGEN
®
 464 
(Figure 6.2). The microbeads in either dispersant were obtained from the same fabrication 
batch. Therefore, it can be concluded that ADOGEN
®
 464 is capable of stabilizing 
agarose core templates in 1-butanol as no significant aggregation or shrinking of the 
agarose microbeads were observed.  
 
6.3.2 Demonstration of Non-Ionized Polyelectrolyte (niPolyelectrolyte) 
Multilayer Coating onto ADOGEN® 464 Stabilized Agarose Microbeads 
for the Organic Phase Fabrication of Core-Shell Materials  
 
Coating of non-ionized polyelectrolyte (niPolyelectrolyte) poly(allylamine) (niPA)  
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Figure 6.3. Fluorescence intensity (pixel value) of agarose microbeads coated with niPA 
(odd layer) and niPAA/niPAA-Rho123 (even layer) as a function of layer number. The 
increasing trend of fluorescence intensity confirms the coating of niPolyelectrolytes onto 
ADOGEN® 464 stabilized agarose microbeads via the RP-LbL technique. (Bai et al., 
2009, Reproduced by permission of The Royal Society of Chemistry) 
 
and poly(acrylic acid) (niPAA) onto agarose microbeads via the RP-LbL technique was 
performed in 1-butanol with a cationic surfactant (ADOGEN
®
 464). However, using 
surfactants might affect the coating of niPolyelectrolyte multilayers onto the surface of the 
agarose microbeads. Therefore, the coating of niPolyelectrolyte multilayers onto 
ADOGEN
®
 464 surface stabilized agarose microbeads, for the organic phase fabrication 
of core-shell materials, was demonstrated with the deposition of fluorescence niPAA-
Rhodamine 123 (niPAA-Rho123). The fluorescence intensity of agarose microbeads after 
each niPolyelectrolyte layer coating (non-ionized poly(allylamine) (niPA) or niPAA-
Rho123) was measured by analyzing the fluorescence micrographs of agarose microbeads 
based on densitometry and represented by pixel values using ImageJ software. Figure 6.3 
shows the fluorescence intensity as a function of the number of niPolyelectrolyte layers 
coated onto the agarose microbeads. It clearly shows a typical fluorescence intensity 
increment when the number of bi-layer coatings increases. This increase in fluorescence 
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intensity is due to niPAA-Rho123 accumulating onto the agarose microbeads after each 
bi-layer coating. Hence demonstrating the successful RP-LbL self-assembly of 
niPolyelectrolyte layers onto ADOGEN
®
 464 stabilized agarose microbeads in 1-butanol 
and the organic phase fabrication of core-shell materials. 
 
6.3.3 Retention Efficiency of Dextran with Different Molecular Weight 
within ADOGEN® 464 Stabilized Agarose Microbeads RP-LbL 
Microcapsules 
For microcapsule applications such as bioreactors and biosensors, it is necessary to 
ensure that the encapsulated biomolecules partaking in the bio-applications do not leach 
out of the microcapsules. Poor retention of the biomolecules will not allow the 
microcapsules to function as desired. Therefore, in the following section, it is desired to 
determine whether if the fabricated core-shell materials described in this chapter can 
efficiently retain encapsulated biomolecules. To demonstrate retention efficiency, dextran 
of different molecular weight (65,000 – 76,000 Da, 155,000 Da, 500,000 Da and 
2,000,000 Da) were pre-loaded into the agarose cores prior to fabrication of the polymeric 
shells via the RP-LbL technique. The agarose microcapsules containing the dextran 
(concentration of 1 mg mL
-1
) are then transferred from 1-butanol to d.d H2O followed by 
an incubation period of 3 days. 
 
Interestingly, pre-loading of TRIS buffer within the agarose results in the fabrication of  
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Figure 6.4. (A) Optical and corresponding (B) fluorescence micrograph of inflated 
microcapsules fabricated with niPAA–Rho123. Fluorescence is observed on the outer ring. 
(C) Optical and corresponding (D) fluorescence micrograph of inflated microcapsules 
fabricated with agarose–Rhodamine 123. The agarose microbeads are clearly fluorescent. 
(E) Confocal optical and corresponding (F) fluorescence micrograph of inflated 
microcapsules fabricated with both niPAA–Rho123 and agarose–Rhodamine 123. The 
agarose microbead is observed to be partially attached to the LbL capsular wall (Bai et al., 
2009, Reproduced by permission of The Royal Society of Chemistry). 
 
“inflated” microcapsules (Figure 6.4) via an osmotic mechanism (Bai et al., 2009). The 
architecture of these microcapsules further emphasizes the formation of the multi-layered 
polymeric shells around the agarose core templates. Studies have been performed on this 
novel group of core-shell materials but will not be mentioned in order to adhere to the 
focus of this thesis. 
 
The retention efficiency of encapsulated dextran of different molecular weight in agarose 
core-shell materials of different layers as a function of time is shown in Figure 6.5. The 0
th
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day represents the fluorescence intensity measured immediately after transferring the 
agarose core-shell materials from 1-butanol to d.d H2O, and the fluorescence intensity of 
dextran with the various molecular weight at 0
th
 day was normalized to 100%. The 
fluorescence intensity measured within individual core-shell materials after dispersion in 
d.d H2O compared to the fluorescence intensity of the respective agarose core-shell 
materials at 0
th
 day reflects the relative retention efficiency (NB: the dextrans of different 
molecular weight were encapsulated individually). From the results obtained, it is 
observed that insignificant loss of dextran with molecular weight of 500,000 Da and 
2,000,000 Da occurred from agarose core-shell materials fabricated with eight RP-LbL  
 
 
Figure 6.5. Relative retention efficiency of dextran with different molecular weight 
(65,000 – 76,000 Da, 155,000 Da, 500,000 Da and 2,000,000 Da) within agarose 
microcapsules fabricated with different number of RP-LbL layers over a period of 3 days. 
The 0
th
 day represents fluorescence intensity measured immediately from the agarose 
microcapsules after transferring the samples from 1-butanol to d.d H2O. The fluorescence 
intensity of dextran with different molecular weight at 0
th
 day was normalized to 100%. 
NB: The dextran of different molecular weight were encapsulated individually. niPA and 
niPAA were used in the RP-LbL technique. 
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layers (of niPA and niPAA) after an incubation of 3 days. In contrast, a steady decline of 
encapsulated dextran with molecular weight 65,000 – 76,000 Da and 155,000 Da within 
agarose core-shell materials fabricated with sixteen RP-LbL layers (of niPA and niPAA) 
was observed over these 3 days of incubation. On the 3
rd 
day, approximately only 25% and 
30% of the encapsulated dextran with molecular weight 65,000 – 76,000 Da and 155,000 
Da respectively were observed to have remained within the agarose core-shell materials of 
sixteen RP-LbL layers. These results indicate that the agarose core-shell materials 
fabricated with (niPA/niPAA)4 and via the RP-LbL technique, were capable of 
encapsulating biomolecules with molecular weight larger than 500,000 Da (radii of 
gyration ~22 nm). However, biomolecules with smaller molecular weight of 65,000 Da 
and 155,000 Da (radii of gyration ~ 9 nm and 13 nm respectively) requires more than 
sixteen RP-LbL layers of coating ((niPA/niPAA)8) to ensure efficient retention of the 
biomolecules (NB: radii of gyration were estimated from the works of Ioan et al., 2000). It 
is also worth noting that the results obtained here for encapsulated dextran with molecular 
weight 65,000 – 76,000 Da and 155,000 Da are sharply in contrast with the results 
obtained in Chapter 5; where MAC RP-LbL microcapsules with 7 RP-LbL layers were 
observed to be able to retain BSA-FITC (~65,000 Da) without significant loss over a 
period of 7 days. Unlike ‘bare' agarose core templates, MACs have amino-PS 
microparticles, which are impermeable to diffusion of biomolecules, distributed on the 
surface and can contribute to retention of these biomolecules within. Therefore, it is very 
likely that the peripheral regions of agarose core-shell materials fabricated with sixteen 
RP-LbL layers, as described in this chapter, are much more porous than that of MAC RP-
LbL microcapsules fabricated with 7 RP-LbL layers as mentioned in the previous chapter. 
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The different retention efficiency of encapsulated biomolecules with similar molecular 
weight was thus observed. It is to note that the retention efficiency of low molecular 
weight biomolecules can be improved by increasing the number of LbL polymer layers 
(Antipov et al., 2001); however this would lead to an increment of the fabrication time and 
thus making the fabrication process time-consuming and not practical. 
 
6.4. Conclusion 
In Chapter 6, it has been demonstrated that hydrophilic agarose microbeads can also 
be stabilized in hydrophobic 1-butanol through the use of a cationic surfactant 
(ADOGEN
®
 464). In addition, it has been demonstrated that LbL polymeric shells, 
consisting of niPA and niPAA, can be fabricated on these ADOGEN
®
 464 stabilized 
agarose core templates via the RP-LbL technique. Through the use of dextran with 
different molecular weight, it has been shown that agarose core-shell materials fabricated 
with eight RP-LbL (of niPA and niPAA) polymer layers were suited to efficiently retain 
dextran with molecular weight larger than 500,000 Da (radii of gyration approximately 
>22 nm) for a period of 3 days. However, agarose core-shell materials fabricated with 
sixteen RP-LbL (of niPA and niPAA) polymer layers were not able to efficiently retain 
dextran with molecular weight of 65,000 – 76,000 Da and 155,000 Da (radii of gyration 
~9 nm and 13 nm respectively), and experienced a steady loss of encapsulated materials 
over 3 days of incubation in an aqueous phase. It is possible to improve the retention 
efficiency by increasing the number of RP-LbL polymer layers but this would cause the 
fabrication process to become time-consuming and not practical. In the next chapter, a 
different and novel method for fabrication of polymeric shells around agarose core 
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templates will be introduced and which can efficiently encapsulate and retain dextran of 
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Chapter 7 – Encapsulation of Biomolecules within 
ADOGEN
®
 464 Stabilized Agarose Microbeads via 
Inwards Deposition of Non-Ionized Poly(allylamine) 
7.1 Introduction 
Microcapsule research has attracted much interest over the past few years in the 
biomedical field and resulted in a wealth of methods for the fabrication of microcapsules 
with polymeric shells. An approach to fabricate polymeric shell microcapsules is through 
manipulating the behavior of materials at the interface of two liquids. With the ability to 
function like surfactants, microparticles have been manipulated and self-assembled at the 
interface of water and oil; and depending on their wettability to form either water-in-oil or 
oil-in-water emulsions (Binks, 2002). Further stabilization of these microparticles at the 
surface of these emulsion droplets gives rise to colloidosomes (Bon et al., 2007; Wang et 
al., 2005) or microcapsules with surface assembled microparticles as a polymeric shell. 
This interfacial self-assembly phenomenon has even been extended to SU-8 polymeric 
microrods for the fabrication of “hairy” colloidosomes (Noble et al., 2004). Another 
method involves the polymerization of two different monomers at the interface of two 
immiscible liquids for the formation of polymeric shells around emulsified droplets 
(Ramarao et al., 2002; Sun and Deng, 2005; Torini, et al., 2005). For example, 
microcapsules with polyurethane shells have been fabricated by interfacial polymerization 
of isophorone diisocyanate (soluble in organic solvent) and 1,6-hexanediol (soluble in 
aqueous solvent) using a oil-in-water emulsion system (Torini et al., 2005). Aside from 
Chapter 7 – Encapsulation of Biomolecules within ADOGEN
®
 464 Stabilized Agarose 
Microbeads via Inwards Deposition of Non-Ionized Poly(allylamine) 
 
 77
interfacial polymerization, the gelation of alginate at the interface of two immiscible 
liquids has been demonstrated to form microcapsules with polymeric alginate shells 
(Zhang et al., 2006). Through the use of microfluidics, solubilized alginate droplets were 
formed in undecanol (containing pre-dissolved calcium iodide). Subsequently, the calcium 
ions in the organic solvent partitioned into the aqueous droplets and gels the alginate near 
the liquid/liquid interface, and thus forming alginate shells around the aqueous droplets. 
 
Since its introduction in 1997 (Decher, 1997), the use of the Layer-by-Layer (LbL) 
polymer self-assembly technique has grown to be one of the more popular methods for the 
fabrication of core-shell materials. In general, polymers are adsorbed onto a core template 
and forms core-shell materials with the LbL polymer multilayer as the polymeric shells 
(Caruso, 2001; Peyratout, and Dähne, 2004). With further processing, certain templates 
such as calcium carbonate (Deng et al., 2007; Volodkin et al., 2004b), gold (Gittins, D.I. 
and Caruso, F, 2000, 2001) and melamine formaldehyde (Caruso, 2000; Ibarz et al., 2002) 
can be dissolved to form hollow microcapsules. Recently, the LbL technique has also been 
performed in an organic phase for the deposition of polymers onto water sensitive core 
templates (Beyer et al., 2007; Borodina et al., 2009). The mechanism of LbL multilayer 
formation in organic phase was demonstrated with the use of FT-IR spectroscopy to 
consist of an acid-base reaction and hydrogen bonding between the anionic and cationic 
polymers (Borodina et al., 2009). 
 
Here, we present a unique and novel phenomenon involving the “inwards deposition of 
concentric non-ionized poly(allylamine) (niPA) layers” within the matrices of agarose 
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microbeads for the fabrication of novel agarose core-shell materials and also for the 
encapsulation of biomolecules. The inwards deposition of niPA is briefly illustrated in 
Scheme 7.1. Agarose microbeads, pre-loaded with biomolecules if desired, are first 
incubated in a 1-butanol solution containing dissolved niPA. Due to the presence of a 
concentration gradient, the niPA diffuses into the peripheral matrices of the agarose 
microbeads and adsorbs onto the agarose polymers. Subsequent niPA polymers diffusing 
into the matrices of the agarose microbeads travel further in and adsorb with any “free” 
agarose polymers; thus forming a thicker polymer layer. The adsorbed niPA polymers can 
then be cross-linked and stabilized with the use of a bi-functional cross-linker for amino 
groups. This allows for the organic phase fabrication of core-shell materials that are stable 
in an aqueous environment and which can efficiently encapsulate and retain pre-loaded 
biomolecules. Interestingly, the separate incubation of niPA covalently modified with 
different fluorescent dyes results in the fabrication of “striated” multi-colored spherical 
shells within agarose microbeads; where these shells of the resultant core-shell material 
can encapsulate biomolecules and encode the agarose core template simultaneously 
(Scheme 7.2). Briefly, agarose microbeads containing the desired biomolecules to be 
encapsulated are first dispersed in 1-butanol. Next, fluorescence labeled niPA in 1-butanol 
is added to the microbead suspension and the 1
st
 concentric colored layer is formed. The 
microbeads are then washed with 1-butanol and incubated with another fluorescence 
labeled niPA in 1-butanol to form the 2
nd
 concentric colored layer. This incubation and 
washing process is repeated accordingly until the desired number and permutation of 
concentric colored layers for encoding purpose is obtained (NB: non-fluorescently labeled 
niPA can also be used for the color encoding).  
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In this chapter, evidence and arguments will be provided that demonstrate the inwards 
diffusion and deposition of niPA polymers within the matrices of the agarose microbeads 
for the organic phase fabrication of core-shell materials. A proposed mechanism for the 
“inwards deposition of concentric niPA layers” technique will also be offered. The 
following results will be presented and discussed as well: 
 Tunable thickness and density of the layers formed by the “inwards deposition of 
concentric niPA layers” technique by changing the percentage of agarose used to 
fabricate the core templates, incubation time of niPA and agarose core templates or 
niPA concentration used for the incubation 
 Stability of the deposited polymeric layers within agarose microbeads dispersed in 
1-butanol and in an aqueous dispersant 
 Stability of the polymeric layers within agarose microbeads dispersed in an 
aqueous dispersant after cross-linking 
 Proof of organic phase fabrication of core-shell materials 
 Encapsulation of biomolecules within the fabricated core-shell materials 
 Retention efficiency and release of encapsulated dextran 
 Fabrication of striated microcapsules for simultaneous agarose core template 
encoding and biomolecules encapsulation 
 Retention of bioactivity of encapsulated enzymes 
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Scheme 7.1. Schematic diagram illustrating the inwards diffusion and deposition of non-




Scheme 7.2. Schematic diagram of the inwards deposition of concentric colored polymer 
layers into the matrices of agarose core templates for the encapsulation of biomolecules 
and encoding. Polymer used is non-ionized poly(allylamine) (niPA). (Bai et al., 2010, 
Reproduced by permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
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7.2 Materials & Methods 
Materials 1-butanol anhydrous 99.8%, disuccinimidyl suberate (DSS), fluorescein 
isothiocyanate (FITC), dithiobis(succinimidylpropionate) (DSP), dextran-TRITC Mw 
65,000 - 76,000 Da, dextran-FITC Mw 4,000 Da, dithiothreitol (DTT), N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), glucose oxidase 
(GOx), horseradish peroxidase (HRP), bovine serum albumin (BSA), D-(+)-glucose and 
mineral oil were purchased from Sigma. Span
®
 80, Ampliflu Red, Rhodamine 123, N-
hydroxysuccinimide (NHS) and tetramethylrhodamine isothiocyanate (TRITC) were 
purchased from Fluka. Poly(allylamine) (PA) Mw 65,000 Da, poly(allylamine 
hydrochloride)-FITC (PAH-FITC) Mw 70,000 Da, 1,1′-carbonyldiimidazole (CDI) and 
ADOGEN
®
 464 were purchased from Aldrich. Low melting agarose was purchased from 
Promega. Ethanol was purchased from Fisher Scientific. Chloroform and hydrogen 
peroxide (H2O2) were purchased from BDH
™
 chemicals. Dimethyl sulfoxide (DMSO) was 
purchased from MP Biomedicals. PBS was purchased from 1
st
 BASE. All materials were 




Scheme 7.3. Molecular structure of (A) disuccinimidyl suberate (DSS) and (B) 
dithiobis(succinimidylpropionate) (DSP). 
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Conjugation of Agarose with Rhodamine 123 Conjugation of agarose with Rhodamine 
123 was performed by first melting the agarose in DMSO before addition of CDI (1 CDI 
monomer: 10 agarose monomer); and allowed to react for 2 hours at 80 °C to activate the 
hydroxyl groups. Rhodamine 123 was then mixed with the activated agarose at a molar 
ratio of 1:100 (Rhodamine 123 molecule: agarose monomer) and incubated for 12 hours at 
45 °C. The agarose-Rhodamine 123 conjugate was then purified by dialyzing against d.d 
H2O at 25 °C for 3 days before drying. The dried agarose-Rhodamine 123 conjugate was 
then weighed and melted in d.d H2O to form an 8% w/v agarose-Rhodamine 123 
hydrogel. 
 
Preparation of Agarose Microbeads An 8% w/v low-melting agarose in d.d H2O was 
prepared and kept molten at a temperature of 45 °C. The agarose solution was diluted with 
d.d H2O to the desired concentration (with the desired biomolecules if required) and then 
added to prewarmed mineral oil at 45 °C containing 0.1% Span 80 (a non-ionized 
surfactant) and stirred vigorously for 10 minutes to form water-in-oil emulsion droplets. 
The droplets were then cooled in an ice water bath while stirring for another 10 minutes to 
allow solidification of the molten agarose droplets into agarose microbeads. The solidified 
agarose microbeads were further stabilized by placing at -20 °C for 5 minutes. 
 
Preparation of Non-ionized and Fluorescence Labeled Poly(allylamine) (niPA) in 1-
Butanol Non-ionized deprotonated poly(allylamine) (niPA) solution was prepared by 
aliquoting PA from the stock solution, drying for 2 days at 80 °C and fully saturating 1-
butanol with the dried PA. The saturated 1-butanol containing the niPA was extracted and 
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1 mL of the 1-butanol extract was dried and weighed; and the amount of deprotonated PA 
was calculated. The 1-butanol extract was then diluted with 1-butanol to prepare a 1 mg 
mL
−1
 niPA solution. Fluorescence labeled niPA was prepared by dissolving and reacting 
FITC or TRITC with niPA in 1-butanol at a ratio of 1:100 (fluorescence molecule: PA 
monomer). The reaction mixture was then left to react for 48 hours at 25 °C. The 1 mg 
mL
−1
 niPA-TRITC was used as prepared while the 1 mg mL
−1
 niPA-FITC was diluted to 
12.5% by using 1 mg mL
−1
 niPA as diluent prior to usage. 
 
“Inwards Deposition of Concentric niPA Layers” into the Matrix of Agarose 
Microbeads The “inwards deposition of concentric niPA layers” was entirely performed 
in 1-butanol. To transfer the agarose microbeads suspension from mineral oil to 1-butanol, 
an equivalent volume of ethanol containing 0.5% ADOGEN
®
 464 was added to the 
suspension and mixed vigorously, followed by centrifugation (1000 rpm, 1 minute). The 
mineral oil and ethanol supernatant was then discarded and the pellet containing the 
agarose microbeads was washed twice with an equivalent volume of 1-butanol containing 
0.5% ADOGEN
®
 464 by centrifugation (1000 rpm, 1 minute) and redispersion cycles. 
The resulting agarose microbeads were then incubated with the desired 
concentrations/volume of niPA or niPA-TRITC or niPA-FITC with 0.5% ADOGEN
®
 464 
for the desired amount of time under gentle vortexing, followed by removal of the excess 
polymer by two washing, centrifugation (500 rpm, 30 seconds) and redispersion cycles. 1-
butanol was used as the dispersant. Typically, 200 µL of beads were incubated with 1 ml 
of the niPA solution. This forms the first concentric layer of niPA. The incubation process 
of beads with niPA solution containing 0.5% ADOGEN
®
 464 was then repeated to form 
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the second and following layers, and until the desired number of concentric niPA layers 
was obtained. (NB: Incubation of niPA without ADOGEN
®
 464 will result in the same 
concentric layer formation. ADOGEN
®
 464, a cationic surfactant was included in the 
fabrication process to ensure that the agarose microbeads do not aggregate or shrink when 
dispersed in 1-butanol). To cross-link the niPA polymers, the agarose microbeads with the 
deposited niPA concentric layers are then further incubated with DSS (dissolved in 
chloroform with a concentration of 40 mg mL
−1
) for 2 hours. Cross-linking is necessary as 
most of the layer forming niPA would otherwise dissolve and disperse once the 
microbeads are transferred into an aqueous dispersant. The resulting agarose microbeads 
were then washed twice with 1-butanol and twice with ethanol using centrifugation (800 
rpm, 30 seconds) and re-dispersion procedures. To transfer the agarose microbeads from 
ethanol into 0.01× PBS, a stepwise approach using decreasing ratios of ethanol: PBS were 
used. The agarose microbeads with the cross-linked niPA in ethanol were first dispersed in 
90% ethanol/10% 0.01× PBS followed by 50% ethanol/50% 0.01× PBS using 
centrifugation and re-dispersion procedures (1000 rpm, 30 seconds). Finally, the resultant 
agarose microbeads were transferred into 0.01× PBS. 
 
Relative Retention Efficiency Study 1 mg mL
-1
 of dextran-FITC (4,000 Da) was first 
emulsified within agarose (4%) microbeads (final volume = 200 µL). Next, polymeric 
layers around each microbead were fabricated using 1.5 mL of 1 mg mL
-1
 niPA and an 
incubation time of 30 minutes. These microbeads were finally incubated for 2 hours with 
an excess of DSS to cross-link the niPA only. The retention efficiency study was 
performed by transferring these agarose microcapsules containing the dextran-FITC into 
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d.d H2O and analyzing the FITC fluorescence intensity originating from individual 
microcapsules; where the fluorescence intensity reflects the quantity of encapsulated 
dextran-FITC. 
 
Determination of niPA Concentration Left in Supernatant 500 µL of 1 mg mL
-1
 niPA-
FITC was used for each layer. The agarose microbeads were centrifuged after incubation 
and the supernatant was checked for fluorescence using a microplate reader (FLUOstar 
OPTIMA, BMG LABTECH, Germany). The concentration of niPA-FITC left in the 
supernatant for each layer was determined by comparing against the stock niPA-FITC 
solution used. 
 
Enzymatic Analysis Enzymatic analysis of GOx and HRP was performed by using 5 mg 
mL
-1
 glucose in 1x PBS, 0.02% H2O2 in 1x PBS and 5 mg mL
-1 
Ampliflu Red in DMSO. 
 
Fourier Transform Infrared (FT-IR) Spectroscopy Samples for the FT-IR 
spectroscopy was prepared by drying overnight at 25 °C. 2 mg of sample was then 
compressed with 98 mg of potassium bromide into a pellet. The pellets were analyzed 
with a FT-IR spectroscope (Bio-Rad FTS-3500ARX, Bio-Rad Laboratories, USA) 
 
Optical, Fluorescence and Confocal Fluorescence Microscopy Phase contrast and 
fluorescence microscopic images were recorded using a CCD color digital camera (Retiga 
4000R, QImaging, Canada) connected to a system microscope (Olympus BX41, Japan). 
Images were captured with QCapture Pro software (Version 5.1.1.14, QImaging, Canada). 
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Bandpass filters with λex 488 nm and λem 520 nm were used for Rhodamine 123 and FITC 
detection while bandpass filters with λex 560 nm and λem 630 nm were used for TRITC 
detection. Confocal optical and fluorescence microscopic images were captured using a 
laser scanning confocal microscope (FluoView™ FV300, Olympus Corporation, Japan). 
All size and fluorescence intensity measurements of the resultant images were analyzed by 
using ImageJ software (Scion Corp., USA). 
 
7.3 Results and Discussion 
7.3.1 Inwards Deposition of Concentric Polymer (Non-Ionized 
Poly(allylamine) (niPA)) Layer within the Matrices of Agarose 
When an aqueous solvent is used, the incubation of agarose microbeads with 1 mg 
mL
-1
 poly(allylamine hydrochloride)-FITC (PAH-FITC) (which are both oppositely 
charged (Mak, W.C. et al., 2008a)) results in the deposition of polymer within the entire  
 
 
Figure 7.1. Overlay optical transmission and confocal fluorescence micrograph of a 
representative microbead after incubation of PAH-FITC and agarose microbeads in an 
aqueous solvent. 
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Figure 7.2. (A) Optical transmission and (B) confocal fluorescence micrographs of 
agarose microbeads after incubation with niPA-FITC in 1-butanol. A concentric ring of 
niPA-FITC with relatively uniform thickness can be observed around each microbead. 
 
matrices of the agarose microbeads (Figure 7.1). In contrast, the incubation of agarose 
microbeads with niPA-FITC (at the same polymer concentration and volume, and with the 
same incubation time) in an organic phase (1-butanol) results in a different deposition 
phenomenon (Figure 7.2). 
 
Optical transmission (Figure 7.2A) and confocal fluorescence (Figure 7.2B) images taken 
from agarose microbeads incubated with niPA-FITC in 1-butanol demonstrate that the 
niPA-FITC polymers have formed a concentric layer around each agarose microbead (The 
concentric layer can also be formed with unmodified niPA). Also, the layers are noted to 
form with near uniform micrometer thickness. It had been demonstrated that 
poly(allylamine) can be deposited onto a template, in a LbL fashion and using cross-
linkers, to form a multilayer polymeric shell around each template (Tong, W. et al., 2006). 
However, as no cross-linkers were applied for the deposition process here, the concentric  
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Figure 7.3. (A) Optical transmission and (B) confocal fluorescence micrographs of 
Rhodamine123 labeled agarose microbead after incubation with niPA in 1-butanol. By 
comparing these two images, fluorescence can be deduced to be emitting from the niPA 
layers and indicates the deposition of niPA within the agarose matrices. (Bai et al., 2010, 
Reproduced by permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
 
polymer layers are very likely formed by niPA depositing into the peripheral matrices 
rather than growing from the surface of each agarose core template. To confirm the 
hypothesis, Rhodamine 123- labeled agarose microbeads are prepared and incubated with 
non-fluorescence niPA.  
 
Optical transmission (Figure 7.3A) and confocal fluorescence (Figure 7.3B) images of a 
representative resultant microbead demonstrate that fluorescence was originating from the 
non-fluorescent niPA layer (between white arrows), thus confirming our hypothesis that 
the niPA was indeed depositing within the matrices of the agarose core templates. To 
further verify our hypothesis that the niPA is depositing inwards into the matrices of the 
agarose microbeads, the agarose microbeads were incubated with alternating niPA-FITC 
and niPA-TRITC. Overlay bright field and confocal images of agarose microbeads in 1-
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butanol, and with different number of concentric colored layers fabricated with 
fluorescently labeled niPA are shown in Figure 7.4. The 1
st
 colored concentric layer is 
formed by incubation with niPA-FITC (Figure 7.4A) whereas the 2
nd
 layer is formed with 
niPA-TRITC (Figure 7.4B). This incubation process is repeated sequentially with niPA-
FITC and niPA-TRITC to form agarose microcapsules with 3, 4, 5 and 6 internal 
concentric colored layers (Figures 7.4C, 7.4D, 7.4E and 7.4F respectively). It is clearly 
evident from these sequential images that the concentric colored layers always form from 
the interior surface of previously formed colored layer(s) i.e. the concentric colored layers 




Figure 7.4. Overlay of optical transmission and confocal fluorescence micrographs of 
agarose microbeads with different number of niPA concentric layers. (A) 1 layer (niPA-
FITC) (B) 2 layers (niPA-FITC/niPA-TRITC) (C) 3 layers (niPA-FITC/niPA-
TRITC/niPA-FITC) (D) 4 layers ((niPA-FITC/niPA-TRITC)2) (E) 5 layers ((niPA-
FITC/niPA-TRITC)2/niPA-FITC) (F) 6 layers ((niPA-FITC/niPA-TRITC)3). The insets 
are magnified images of the fluorescence layers. (Bai et al., 2010, Reproduced by 
permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
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7.3.2 Diffusion and Deposition of niPA into the Agarose Microbeads 
and the Influence of Incubation Time, niPA Concentration and 
Agarose Concentration on the Thickness of the Deposited niPA Layer  
   
   
Figure 7.5. (A) Layer thickness (□) and average layer fluorescence intensity (●) as a 
function of incubation time. (B) Layer thickness (□) and average layer fluorescence 
intensity (●) as a function of incubated niPA concentration. (C) Layer thickness (□) and 
average layer fluorescence intensity (●) as a function of percentage of agarose used to 
fabricate the microbeads. (NB: The thickness and average fluorescence intensity of the 
polymer layers were measured from microcapsules with an average diameter of ~175 µm). 
The lines and arrows only serve to guide the eyes. 
 
To further understand the deposition mechanism of niPA within the peripheral 
matrices of agarose core templates, the influence of three factors on the “inwards 
deposition of concentric niPA layers” are studied: i) different incubation time of niPA (1 
mg mL
-1
) with 2% agarose microbeads (Figure 7.5A), ii) different concentrations of niPA 
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used for a fixed incubation time (30 minutes) and with 2% agarose microbeads (Figure 
7.5B) and iii) different percentage of agarose used to fabricate the microbeads with a fixed 
niPA concentration (1 mg mL
-1
) and incubation time (30 minutes) (Figure 7.5C). (NB: 
The thickness and mean fluorescence intensity (line profile of thickness) of the polymer 
layers were measured from microbeads with an average diameter of ~175 µm. niPA-FITC 
was used to obtain the mentioned measurements). From the results of Figure 7.5A, it is 
observed that the thickness of the deposited niPA layers increases when incubation time 
increases. A corresponding decrease of polymer concentration is also detected in the 
supernatant with more than 85% loss after 30 minutes of incubation (data not shown), 
suggesting that the layer thickness have increased due to more niPA entering into the 
agarose peripheral matrices. Using a fixed incubation time (30 minutes), Figure 7.5B 
demonstrates that the thickness of the polymer layer also increases when the concentration 
of niPA increases. Common to both sets of experiments, an increase in average 
fluorescence intensity (pixel values) of the layers is also observed. This can be adequately 
explained if one considers the niPA to be entering the agarose matrices by diffusion. 
When the incubation time and amount of incubated niPA are increased, more niPA can 
diffuse into the agarose microbead, thus resulting in a polymer layer within the agarose 
peripheral matrices which is thicker and with higher fluorescence intensity. In summary, 
the thickness of the deposited polymer layer within each agarose core template depends on 
and can be tuned by the incubation time and amount of incubated niPA. 
 
On the other hand, increasing the percentage of agarose used results in a decrease of layer 
thickness and is accompanied by an increase in average fluorescence intensity as observed 
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in Figure 7.4C. This observation indicates that more niPA is being packed into the matrix 
per unit volume (or increment of polymer density) of the concentric polymer layers when 
the core template consist of more agarose polymers. This implies that density of the 
polymer layers can also be tuned by changing the percentage of agarose. It also indicates 
that the concentric polymer layers are likely formed by an interaction of the niPA with the 
agarose polymers and not by “filling up” the pores within the hydrogel matrices.  
 
Surprisingly, the concentric polymer layers formed via the “inwards deposition of 
concentric niPA layers” are observed to be extremely stable provided the agarose core 
templates are still dispersed in 1-butanol. The average layer thickness (10.97 ± 0.55 µm) 
and fluorescence intensity of the polymer layers (1953 ± 191 pixel values) at time 0 hour 
(Figure 7.6A) can still be observed (11.29 ± 0.54 µm / 1960 ± 109 pixel values) after 48 
hours (Figure 7.6B) of incubation in 1-butanol. This stability indicates that the concentric 
layers are being formed through “immobilization” of the niPA and not because of 
diffusion hindrance from the agarose matrices. However, the stability of the polymer 
layers is immediately lost once the agarose microbeads are transferred into an aqueous 
phase (nearly more than 90% loss of fluorescence intensity from the layer is observed, 
demonstrating that most of the polymers are lost from the layer (data not shown)). This 
indicates that the concentric polymer layers are formed by a special interaction, which is 
present under the influence of an organic environment, between the niPA and agarose 
polymers. 
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Figure 7.6. Confocal fluorescence micrographs of a (A) representative agarose microbead, 
incubated in 1-butanol, with a niPA-FITC layer at Time 0 hours (B) representative agarose 
microbead, still incubated in 1-butanol, with a niPA-FITC layer at Time 48 hours. Insets 
are the plot profiles (yellow line). (Bai et al., 2010, Reproduced by permission of Wiley-
VCH Verlag GmbH & Co. KGaA) 
 
7.3.3. Proposed niPA Deposition Mechanism into the Matrices of 
Agarose Microbeads 
It had been reported previously that when alginate microbeads were dispersed in 
ethanol, an exchange of water (within the alginate matrices) and ethanol solvent would 
take place (Doumèche et al., 2002). As ethanol is used as an intermediate solvent to 
transfer the agarose microbeads from oil to 1-butanol and no significant changes in size 
distribution can be observed (Figure 6.2), this suggests that the internal content of agarose 
microbeads in 1-butanol is very likely to have undergone a similar solvent exchange 
process, thus resulting in the agarose matrices to be significantly filled with 1-butanol. 
However, a complete exchange of solvents and thus removal of all water molecules is not 
possible as water molecules are required to maintain the integrity of the agarose 
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microbead structure (Labropoulos et al., 2002). The niPA polymer can be considered to be 
hydrophilic due to its numerous amino side groups and high water solubility (>200 mg 
mL
-1
). Using 1-butanol as a solvent for niPA results in a niPA solution of relatively low 
concentration (average maximum solubility obtained was ~2.3 mg mL
-1
). Due to this poor 
solubility of niPA in 1-butanol, the incubation of niPA with the hydrophilic agarose 
hydrogel will first result in the in-diffusion of niPA into the peripheral matrices of agarose 
microbeads which is driven by a concentration gradient between the external solution and 
internal agarose matrix. Following, a preferential interaction with and adsorption of niPA 
onto the agarose polymers (Fleer, G.J. et al., 1993) take places and thus contributes to the 
formation of the concentric niPA layers. Upon transferring to an aqueous solvent (i.e. 
removal of 1-butanol), this preferential interaction of niPA with agarose polymers is lost 
and the niPA begins to dissociate before depleting into the aqueous solvent. However, a 




Figure 7.7. FT-IR spectra of dried samples from (A) niPA and (B) agarose microbeads, 
agarose microbeads incubated with niPA and then transferred to d.d H2O; and agarose 
microbeads incubated with niPA and retained in 1-butanol. 
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FT-IR spectroscopy was used to understand the interactions between niPA and agarose 
polymers after adsorption. The FT-IR spectrum of niPA reveals a strong peak at 1640 
cm
−1 
(deformation of –NH2) (Figure 7.7A). In addition, dried samples of (i) agarose 
microbeads (dispersed in 1-butanol), (ii) agarose microbeads incubated with niPA in 1-
butanol, transferred to and washed with double distilled water (d.d H2O); and (iii) agarose 
microbeads incubated with niPA in 1-butanol (and retained in 1-butanol) were analyzed 
and the results are shown in Figure 7.7B. A new peak at 1567 cm
−1
 (attributed to 
deformation of –NH3
+
) is found for samples (ii) & (iii) and is likely to have shifted from 
1640 cm
−1
 after niPA had interacted with the agarose polymers, resulting in an acid-base 
reaction to form ammonium salts. A higher intensity was observed for sample (iii) as the 
microbeads were not transferred to an aqueous solvent and hence would consist of 
significantly more niPA The peak observed at 1322 cm
−1
 for only sample (iii) is probably 
shifted from 1260 cm
−1
 (deformation of O−H bonds from primary alcohols of agarose) as 
a result of the interaction of -OH groups (deprotonation) from the agarose polymers with 
niPA whilst in 1-butanol. The peaks of higher intensity at  1480 cm
−1
 (deformation of 
−CH2) observed in the spectra of (i) & (iii) is probably contributed by the cationic 
surfactant used to stabilize agarose microbeads in 1-butanol and the broader peak in 





 were also observed for all three samples which correlate to symmetric and 
asymmetric stretching of −CH2 respectively (data not shown). Therefore, the FT-IR 
spectra obtained from these three samples reveals that upon preferential adsorption of 
niPA with agarose polymers in 1-butanol, the niPA interacts and very likely associates 
with the agarose polymers by electrostatic interactions. The presence of hydrogen bonding 
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between niPA and agarose polymers was hard to discern but cannot be discounted. 





and broad peaks were observed for all samples 
involving agarose (data not shown) at this range. The broad peaks are believed to have 
resulted from the hydrogen bonding between agarose polymers to maintain the matrix 
structure. The likely presence of −NH3
+
 groups can explain the reduced fluorescence 
intensity observed within the niPA layer in Figure 7.3B. As the deposited niPA and the 
Rhodamine 123-agarose polymers are in such close proximity, a fluorescence quenching 
effect via electron-transfer process (Eriksen and Foote, 1978; Grellmann et al., 1972) 
would occur from the excited fluorescent dyes to the electron deficient −NH3
+





Figure 7.8. Confocal fluorescence micrograph demonstrating the deposition of niPA-
FITC into the core of agarose microbeads. These microbeads were imaged after incubation 
with (niPA-FITC/niPA)2/niPA-FITC and the niPA can be observed to have filled the core 
of the agarose microbeads. (Bai et al., 2010, Reproduced by permission of Wiley-VCH 
Verlag GmbH & Co. KGaA) 
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Figure 7.9. Micrograph of equivalent volume of hydrogel microbeads dispersed in 1-
butanol after 2 weeks of incubation with excess niPA dissolved in 1-butanol (left tube: 
+ve control) or with 1-butanol only (right tube: -ve control). For both tubes, no significant 
changes in volume were observed but a slight change in opacity could be observed after 2 
weeks for the left tube (the change in opacity is caused by the absorption of niPA by the 
agarose microbeads). (Bai et al., 2010, Reproduced by permission of Wiley-VCH Verlag 
GmbH & Co. KGaA) 
 
Previous works involving the active transport of linear polyions into oppositely charged 
hydrogels (Kabanov et al., 1989; Rogacheva et al., 1988; Zezin et al., 1994) exhibit 
similar results as observed in this chapter. It is worth noting that the fundamentals 
involved in the “inwards deposition of concentric polymer layers” are evidently different 
from the “active transport of linear polyions into oppositely charged hydrogels” and to the 
“outwards” deposition of LbL layers. Comparing our fabricated polymer-hydrogel layers 
with those formed from linear polyions actively transported into oppositely charged 
polyelectrolyte hydrogels (Kabanov et al., 1989, 2004; Oh et al., 2007; Rogacheva et al., 
1988; Zezin et al., 1994), it can be noted that both works describe layered and stable 
polymer-hydrogel aggregate within the hydrogel, and occupation of the entire hydrogel 
volume by the polymer (Figure 7.8). However, there are fundamental differences that 
distinguish the “inward deposition of concentric niPA layers” technique. Firstly, the 
microbeads do not exhibit significant shrinking after 2 weeks of incubation with excess 
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niPA (Figure 7.9). Next, the direction of polymeric layer ‘growth’ is inwards after passing 
through previously formed layers and not via a ‘relay-race’ migration (Kabanov et al., 
1989) of polymeric layers. In ‘relay-race’ migration, a bound polymer is substituted and 
“pushed” inwards by a new incoming polymer. Therefore, the direction of layer ‘growth’ 
in our experiments highly supports the fact that the “inwards deposition of concentric 
niPA layers” is a result of niPA diffusing inwards, passing any niPA-agarose complex, 
and forming a complex with the next “free” agarose polymer. 
 
To summarize, the following deposition mechanism is proposed for the “inwards 
deposition of concentric niPA layers” technique. Upon incubation of niPA with agarose 
core templates dispersed in 1-butanol, a concentration gradient between the exterior and 
interior of the agarose core templates is established and causes the niPA to diffuse into the 
agarose matrices. Any niPA polymer entering the agarose matrices will initially come into 
close contact with the peripheral agarose polymers and due to the poor solubility of niPA 
in 1-butanol, it preferentially adsorbs and interacts with the agarose polymers resulting in 
complex formation and electrostatic interaction between the amino groups of the niPA and 
the hydroxyl groups of agarose polymers. The combination of adsorption and interaction 
will therefore cause the niPA to “occupy” and “immobilize” onto the agarose polymers. 
Subsequent niPA diffusing into the agarose matrices will bypass any “occupied” agarose 
polymers and interact with the next “free” agarose polymer; thus getting “immobilized” as 
well and thereby creating a thicker deposited niPA layer. This process will continue until 
no more “free” agarose polymer is available or until all or most of the niPA in the 1-
butanol have been deposited in the matrices.  
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7.3.4. Organic Phase Fabrication of Core-Shell Materials via the 
Inwards Diffusion and Deposition of niPA Layers into the Matrices of 
Agarose Microbeads. 
To fabricate polymeric shells within the matrices of agarose microbeads, 
disuccinimidyl suberate (DSS) (a homobifunctional cross-linker for amino groups) is 
incubated with the agarose microbeads containing the concentric niPA layers prior to 
transferring the microbeads into an aqueous dispersant. Addition of DSS was performed  
 
 
Figure 7.10. FT-IR spectra of dried samples from agarose microbeads incubated with 
niPA and then transferred to d.d H2O; and agarose microbeads incubated with both niPA 
and a homobifunctional amino group cross-linker (DSS) before being transferred to d.d 
H2O. 
 
so as to cross-link the niPA polymers within the agarose matrices and to prevent the loss 
of niPA polymers after transferring into an aqueous phase. FTIR spectroscopy of dried 
samples of agarose microbeads incubated with niPA and DSS, and subsequently dispersed 
in an aqueous solvent (Figure 7.10) demonstrated a peak at 1248 cm
−1
 (stretching of 
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−CNH in an amide bond) and strong peaks at 1557 cm
−1
 (stretching of −CN and 
deformation of −NH in an amide bond) and 1640 cm
−1
 (stretching of −C=O in an amide 
bond). This demonstrates the successful cross-linking and formation of amide bonds 
between niPA and DSS. A broad peak of 1444 cm
−1
 was also observed and likely due to a 
significantly higher amount of niPA present (deformation of −CH2) or from the presence 
of unreacted carboxylic groups of the cross-linker (stretching of C=O). 
 
   
 
Figure 7.11. Confocal fluorescence micrographs of Rhodamine 123 labeled agarose 
microbead with a concentric layer of niPA-TRITC (A) before and (B) after heat treatment. 
 
Cross-linked niPA-TRITC layers within Rhodamine 123 labeled agarose microbeads were 
fabricated and then subsequently left in a water bath of 80 °C to melt the agarose as proof 
that core-shell materials are indeed fabricated. By comparing the confocal fluorescence 
images of the cross-linked niPA-TRITC in Rhodamine 123 labeled agarose microbeads 
before (Figure 7.11A) and after (Figure 7.11B) heat treatment, it is observed that the 
Rhodamine 123 fluorescence is lost from the core after heat treatment while the 
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fluorescence from cross-linked niPA-TRITC shell is still retained. This indicates that upon 
subjecting the cross-linked niPA agarose microbeads to heat treatment, the agarose melts 
and loses their three dimensional network structure. Following, the agarose polymers 
(120,000 Da) are able to diffuse through the heated polymer shells (formed by the cross-
linked niPA) and escape into the bulk solution. This also suggests that the pore size of the 
heated niPA shell is large enough to allow movement of macromolecules with a molecular 
weight of at least 120,000 Da. As polymeric shells of cross-linked niPA-TRITC are 
observed after melting away the agarose, this confirms that the unique phenomenon of 
“inwards deposition of concentric niPA layers” into the matrices of the agarose 
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7.3.5. Spatial Distribution, Retention Efficiency and Release of 
Encapsulated Dextran from Core-Shell Materials Fabricated via 
Inwards Deposition of niPA. 
 
Figure 7.12. Overlay of optical transmission and confocal FITC fluorescence micrographs 
of agarose core-shell materials encapsulating dextran-TRITC (65,000 – 76,000 Da) and 
with one concentric layer of niPA-FITC while in (A) 1-butanol or (B) in an aqueous 
dispersant. Corresponding confocal TRITC fluorescence images of the encapsulated 
dextran-TRITC (65,000-76,000 Da) in (C) 1-butanol or (D) in an aqueous dispersant. (Bai 
et al., 2010, Reproduced by permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
 
The encapsulation of biomolecules was demonstrated by using dextran-TRITC (65,000–
76,000 Da) as it cannot be cross-linked by DSS and is a non-charged polymer. Figure 7.12 
shows the distribution of dextran-TRITC within agarose core-shell materials of one cross-
linked concentric niPA-FITC layer (fabricated with 1 mL 1 mg mL
-1
 niPA, 30 minutes 
incubation and 200 µL of agarose microbeads). Figure 7.12A and 7.12B are overlays of 
optical transmission and confocal FITC images of the agarose core-shell materials with 
one concentric layer of niPA-FITC whilst in 1-butanol and in an aqueous dispersant 
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respectively. Figure 7.12C and 7.12D are the corresponding confocal TRITC images of 
the encapsulated dextran-TRITC within the core-shell materials. The encapsulated 
dextran-TRITC is observed to be distributed within the core of the agarose microcapsules 
whilst in 1-butanol (Figure 7.12C) but entrapped within regions of where the cross-linked 
niPA layer resides and not homogeneously distributed in the centre when the core-shell 
materials were dispersed in an aqueous dispersant (Figure 7.12D). This non-homogeneous 
distribution of encapsulated dextran is similarly reported in hollow LbL microcapsules 
(Antipov et al., 2002; Volodkin et al., 2004a). As dextran-TRITC cannot be cross-linked 
by DSS and is non-charged, it can be concluded that the dextran is likely to have been 
physically ‘entangled’ and entrapped within the cross-linked niPA shells. This entrapment 
occurred when the microcapsules were transferred from 1-butanol to an aqueous phase; 
where a concentration gradient was established between the interior and exterior aqueous 





Figure 7.13. (A) Optical transmission micrograph of agarose microbeads encapsulation 
dextran-TRITC (65,000 – 76,000 Da) and with one concentric layer of niPA cross-linked 
with dithiobis(succinimidylpropionate) (DSP). Corresponding TRITC fluorescence 
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By using cross-linkers that can be cleaved internally (e.g. possessing central disulfide 
group such as dithiobis(succinimidulpropionate) (DSP) (Scheme 7.3B)), fabrication of 
agarose core-shell materials via the “inwards deposition of concentric niPA layers” 
technique may have potential release applications. Figure 7.13 depicts the release of 
encapsulated dextran-TRITC (65,000 – 76,000 Da) from agarose microbeads with one 
concentric layer of niPA (fabricated with 1 mL 1 mg mL
-1
 niPA, 30 minutes incubation 
and 200 µL of agarose microbeads) and cross-linked with excess DSP. Release was 
activated with the introduction of 50 mM dithiothreitol (DTT), where DTT acts as a 
reducing agent capable of cleaving the central disulfide bond of DSP. Prior to addition of 
DTT (Figure 7.13B), it was observed that fluorescence from the encapsulated dextran can 
only be prominently observed from the agarose core-shell materials. However, after the 
introduction of DTT, the fluorescence from the agarose microcapsules is observed to 
decrease over time (Figure 7.13C and 7.13D) and a concomitant increase in fluorescence 
in the background surrounding each microcapsule can be observed; thus highlighting the 
release of encapsulated dextran-TRITC from the agarose microcapsules. Other possible 
cross-linkers of niPA having different possible release mechanisms include disuccinimidyl 
tartarate (central diol group) and bis[2-(succinimidyloxycarbonyloxy)ethyl]sulfone) 
(central sulfone group). Release of dextran was initiated by reduction of the disulfide 
bonds by DTT. This cleaves the bonds and disintegrates the network of cross-linked niPA 
from within the peripheral matrices of the agarose microbeads, and the niPA consequently 
dissolves and disperses into the surrounding aqueous phase. Without a stable polymeric 
shell to entrap the encapsulated materials, the dextran will thus diffuse out of the agarose 
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microbeads. In summary, introduction of a cleaving agent (DTT in this case) results in the 
release of both the niPA and encapsulated contents into the surrounding dispersant. 
 
    
Figure 7.14. (A) Relative retention efficiency of dextran-FITC (4,000 Da) within agarose 
microbeads with one layer of concentric niPA layer cross-linked with DSS. The 
microcapsules were incubated in d.d. H2O over a period of 5 days. The 0
th
 day represents 
fluorescence intensity measured immediately after transferring the samples from 1-butanol 
to d.d H2O and agarose microcapsules at 0
th
 day were taken as 100 %. (B) Fluorescence 
micrograph of encapsulated dextran-FITC within the agarose microcapsules on Day 5. 
 
Unlike polymeric shells fabricated via using the LbL technique, the polymeric shells 
fabricated here via the “inwards deposition of concentric niPA layers” technique are 
significantly thicker. Using the LbL technique typically results in shells of thickness in the  
nanometer range whereas the works here describe shells of thickness in the micrometer 
range (Figure 7.5). Therefore, it would be interesting to study the retention efficiency of 
macromolecules with low molecular weight within agarose core-shell materials of a single 
cross-linked niPA layer fabricated via the “inwards deposition of concentric niPA layers” 
technique. Dextran-FITC (4,000 Da, radii of gyration ~2.5 nm (Ioan et al., 2000)) was 
encapsulated within agarose core-shell materials with a single niPA layer and Figure 
7.14A shows the relative retention efficiency of the encapsulated dextran-FITC within the 
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agarose core-shell materials during a 5 day incubation period in d.d H2O. See 
experimental section for fabrication details. The 0
th
 day represents the fluorescence 
intensity measured immediately after transferring the samples from 1-butanol to d.d H2O 
and the fluorescence intensity of agarose microcapsules obtained at the 0
th
 day were taken 
as 100% retention efficiency. The fluorescence intensities measured within individual 
core-shell materials after dispersion in d.d H2O, at different days, compared to the 
fluorescence intensity of core-shell materials at the 0
th
 day reflects the relative retention 
efficiency. The intense FITC fluorescence and low background noise observed in Figure 
7.14B highlights that significant amounts of dextran-FITC (4,000 Da) had been entrapped 
within these fabricated agarose core-shell materials. From the results as shown in Figure 
7.14, agarose core-shell materials fabricated via the “inwards deposition of concentric 
niPA layers” technique can retain ~95% of dextran-FITC (4,000 Da) after 5 days of 
incubation in d.d. H2O. Therefore, it can be concluded that the thick polymeric shell 
formed via the “inwards deposition of concentric niPA layers” technique has the ability to 
retain macromolecules with radii of gyration of approximately 2.5 nm. 
 
7.3.6. Encoding of Agarose Microbeads via the “Inwards Deposition of 
Concentric niPA Layers” Technique 
From the images shown in Figure 7.4, it was observed that distinct colored layers can 
be obtained through the separate incubation of niPA conjugated to different dyes. It would 
therefore be interesting to determine if the “inwards deposition of concentric niPA layers” 
technique could be used for encoding of the agarose core templates. Encoding of the  
 
Chapter 7 – Encapsulation of Biomolecules within ADOGEN
®
 464 Stabilized Agarose 





Figure 7.15. (A) Layer thickness of concentric layers as a function of layer number. 
Doubling of the niPA volume causes an increase in concentric layer thickness for same 
incubation time (15 minutes). Inset is a visual definition of layer number. (B) Layer 






 layer as a function of incubation time (constant volume 
and niPA concentration). (Bai et al., 2010, Reproduced by permission of Wiley-VCH 
Verlag GmbH & Co. KGaA) 
 
microcapsules was found to be achievable through color and layer thickness permutation; 
thereby providing up to 2 levels of encoding for each agarose core-shell material. The 
general steps for agarose microbead encoding via the “inwards deposition of concentric 
niPA layers” technique are shown in Scheme 7.2. The thickness of each layer is 
demonstrated to be tunable by varying the amount of niPA present during incubation 
(Figure 7.15A) or by changing the incubation time (Figure 7.15B) (N.B: only 
microcapsules with diameters ~175 µm were analyzed). It can be observed that the layer 
thickness increases i) when the layer number increases, ii) when the agarose microbeads 
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are exposed to a larger quantity of niPA and iii) when the incubation time is increased. An 
almost constant fluorescence intensity of the layers was also observed (Figure 7.16) which 
indicates that there is a constant capacity within the agarose microbeads to form 
complexes with the niPA and also that the thicker layer thickness observed is not due to 
niPA spreading out within the microbead. Only the thickness of the 1
st
 layer was observed 
not to significantly increase when the incubation time was changed. This points out that 
equilibrium was reached and is supported by the fact that most of the niPA had already 
formed the 1
st
 layer after 5 minutes (>80% loss of niPA-FITC in supernatant). Although 
one would expect a reduction in subsequent layer thickness as more layers are deposited 
(diffusion barrier increases), the layer thickness increases with increasing layer number 
(identical niPA volume incubation) instead (Figure 7.15A). This is due to two factors: i) a 
reduction of adjacent free inner volume and ii) the mass of polymer forming the next layer 
to be similar to that of the previously deposited layer (Figure 7.17). In cases where 
equilibrium of the system was not reached, thicker layers could be obtained with an 
increase in incubation time (Figure 7.15B). In summary, the thickness of the formed layers 
is governed by three parameters: quantity of niPA (kinetics), equilibrium and volume of 
agarose available for complex formation with niPA. To demonstrate double encoding, 
“striated” shells of different color/thickness permutation were fabricated (Figure 7.18).  
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Figure 7.16. Confocal micrographs of agarose microbeads fabricated with alternating (A) 
niPA-FITC and (B) niPA-TRITC using 500 µL polymer solution and 15 minutes 
incubation time; (C) niPA-FITC and (D) niPA-TRITC using 1 mL polymer solution and 
15 minutes incubation time; (E) niPA-FITC and niPA using 1 mL polymer solution and 
15 minutes incubation time for layers 1 & 2 and 5 minutes for layer 3; (F) niPA-FITC and 
niPA using 1 mL polymer solution and 15 minutes incubation time for layers 1 & 2 and 45 
minutes for layer 3; (G) niPA-FITC and niPA using 1 mL polymer solution and 15 
minutes incubation time for layers 1 to 4 and 5 minutes for layer 5; (H) niPA-FITC and 
niPA using 1 mL polymer solution and 15 minutes incubation time for layers 1 to 4 and 45 
minutes for layer 5. Insets are fluorescence intensity plot profiles obtained at the yellow 
line to highlight the distribution of niPA-FITC or niPA-TRITC. The similar fluorescence 
intensity observed for each fluorescent layer in each plot highlights that the thicker layers 
are a result of more niPA packing into the agarose microbeads and not a result of the 
polymer spreading out within the microbeads. (Bai et al., 2010, Reproduced by permission 
of Wiley-VCH Verlag GmbH & Co. KGaA) 
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Figure 7.17. Remaining percentage of niPA-FITC in the supernatant as a function of layer 
number. The percentage of niPA-FITC remaining in the supernatant increases when the 
layer number increases although the same incubation time was used for each layer. This 
suggests that less polymer is entering the agarose microbeads as more polymer deposits 
into the agarose microbeads; and is probably caused by previously deposited polymer 
acting as a diffusion barrier. Briefly, an increase in the layer number probably creates a 
thicker diffusion barrier for any incoming niPA-FITC and leads to an increase in the 




Figure 7.18. (A-C) Confocal micrographs of agarose microbeads in 0.01× PBS with five 
concentric layers of different color coding permutations. Fabrication was done in the 
following order: Layers 1/2/3/4/5 (A) G/B/R/B/G (B) R/G/R/G/R (C) R/G/R/B/G. R – 
RED, G – GREEN, B – BLANK. (D-F) Confocal images of agarose microbeads in 0.01× 
PBS with three concentric layers (Layer 1/2/3) of the same color encoding permutation 
(R/B/G) but with different thickness permutations due to the use of different volumes of 
polymer. (D) 500 µL /500 µL /500 µL (E) 500 µL /1 mL /500 µL (F) 500 µL /500 µL /1 
mL. The insets in the confocal images are magnified images of the fluorescence layers. 
(Bai et al., 2010, Reproduced by permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
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7.3.7. Bioactivity of Encapsulated Enzymes in Encoded Agarose 
Microcapsules. 
To demonstrate that encapsulated biomolecules can retain their bio-functionality after 
going through the novel “inwards deposition of concentric niPA layers” technique, 
glucose oxidase (GOx) and horseradish peroxidase (HRP) were encapsulated within 
agarose core-shell materials of three cross-linked concentric niPA layers 
((Blank/Green/Blank) and (Blank/Red/Blank) respectively). Bovine serum albumin (BSA) 
was also encapsulated as a control (Red/Blank/Green). The three different types of core-
shell materials are subsequently mixed together to form two different sets: Set 1) HRP and 
BSA microcapsules (Figure 7.19A and 7.19D) and Set 2) HRP and GOx microcapsules 
(Figure 7.19B, 7.19C, 7.19E and 7.19F). Enzymatic activity of the encapsulated GOx and 
HRP is then demonstrated via addition of glucose/Ampliflu Red (AR) and hydrogen 
peroxide (H2O2)/AR respectively. GOx converts glucose in the presence of oxygen into 
gluconolactone and H2O2; and HRP converts AR in the presence of H2O2 into a purple 
coloured product.  
 
Figure 7.19G and 7.19H shows the colour formation observed 10 seconds after addition of 
H2O2/AR to HRP/BSA microcapsules and HRP/GOx microcapsules respectively. Through 
readout of the colour permutations, it can be “decoded” that the purple product is observed 
only for the HRP microcapsules; thereby indicating that HRP can retain its bio-
functionality after going through the fabrication process. Figure 7.19I shows the colour 
formation 2 minutes after addition of glucose/AR. After similar decoding, the purple 
product is only observed at the HRP microcapsules; thus demonstrating that GOx had also 
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retained its bio- functionality. A longer time was necessary for this enzymatic assay to 
form the coloured product as time was required for the H2O2 produced by the GOx 




Figure 7.19. Demonstration of enzymatic viability in microcapsules encapsulating HRP 
(labeled red only) and encapsulating GOx (labeled green only). BSA microcapsules were 
used as a control (labeled green and red). Optical transmission micrographs of (A) HRP 
and BSA microcapsules, (B, C) HRP and GOx microcapsules and corresponding 
overlapping FITC and TRITC fluorescence micrographs of (D) HRP and BSA 
microcapsules and (E, F) HRP and GOx microcapsules before addition of substrates. 
Addition of H2O2 and Ampliflu Red (AR) to the (G) HRP and BSA microcapsules and (H) 
HRP and GOx microcapsules. After 10 seconds, only the HRP microcapsules were 
observed to turn purple. (I) Addition of glucose and AR to the HRP and GOx 
microcapsules. After 2 minutes, only the HRP microcapsules were observed to turn purple. 
(Bai et al., 2010, Reproduced by permission of Wiley-VCH Verlag GmbH & Co. KGaA) 
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In conclusion, a novel “inwards deposition of concentric niPA layers” technique for 
the organic phase fabrication of agarose core-shell materials was demonstrated. Rather 
than random adsorption within the matrices of agarose core templates, the niPA diffuses 
inwards into the agarose peripheral matrices and deposits to form concentric layers of near 
uniform thickness within the agarose core templates. This process was entirely performed 
in 1-butanol and the “inwards deposition of concentric niPA layers” is believed to have 
occurred through a preferential adsorption of niPA onto the hydrophilic agarose polymers 
followed by complex formation and electrostatic interactions between the two polymers. 
The preferential adsorption is attributed to the poor solubility of niPA in 1-butanol. It was 
also demonstrated that the density and thickness of the deposited niPA layers within the 
matrices of the agarose microbeads can be tuned by varying the percentage of agarose 
used to fabricate the templates, incubation time and/or niPA quantity. Through further 
cross-linking of the niPA polymers followed by heat treatment of the agarose microbeads, 
hollow microcapsules with the cross-linked niPA as polymeric shells could be obtained, 
thus demonstrating the organic phase fabrication of novel agarose core-shell materials. 
These polymeric shells were shown to be capable of encapsulating dextran having a 
molecular weight of 4,000 Da and with a retention efficiency of ~95% over 5 days 
incubation in aqueous phase, a challenging task that is rarely reported. Also, release of 
encapsulated materials from these novel core-shell materials can be achieved through the 
use of cross-linkers possessing cleavable groups. 
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Till date, encoding of polymeric core-shell maeterials using fluorescence dyes is 
commonly employed by permutating the ratio of fluorescence dyes used (Gaponik et al., 
2002). The novel “inwards deposition of concentric niPA layers” technique brings 
encoding to a different level where encoding is performed via a color/thickness scheme. 
The encoding process was performed through incubation of niPA, having different 
conjugated fluorescence dye, to form “striated” multi-colored polymeric shells; where the 
colors and thickness of these layers can be permutated to provide 2 levels of encoding 
possibilities. In addition, through the use of GOx and HRP, it was demonstrated that 
biomolecules can be encapsulated within these encoded core-shell materials and can retain 
their bio-functionality. This novel approach should greatly contribute to the field of bio-
analytics, colloidal science and engineering and microencapsulation. For example, 
microcapsule identification in solution or in bio-arrays for multiplexed bio-detections/bio-
reactions. In addition, it is envisioned that different chemical or biological functionalities 
can be incorporated within each layer so as to carry out and possibly visualize different 
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Chapter 8 – Conclusion & Future Works 
8.1 Conclusion 
In this PhD work, the successful organic phase fabrication of core-shell materials for 
the encapsulation of biomolecules was accomplished and demonstrated through three 
different novel methods: i) “Matrix-assisted colloidosomes” (MACs) and RP-LbL 
technique, ii) agarose/ADOGEN
®
 464 and RP-LbL technique and iii) agarose/ADOGEN
®
 
464 and “inwards deposition of concentric niPA layers” technique. All three methods 
were performed in an organic phase to achieve high encapsulation efficiency. The initial 
fabrication step encompasses the fabrication of agarose microbeads, via water-in-oil 
emulsion technique, as core templates and suitable vessels for encapsulation of pre-loaded 
biomolecules (Chapter 4/Specific Aim 1). To minimize loss of the pre-loaded 
biomolecules from the agarose core templates during the core-shell fabrication phase and 
also during subsequent dispersion in an aqueous phase, 1-butanol was chosen for the 
organic phase while non-ionized polyallylamine (niPA) and non-ionized poly(acrylic acid) 
(niPAA) were chosen for the shell fabrication (Chapter 4/Specific Aim 2). However, as 
the hydrophilic agarose microbeads aggregated and shrinked in 1-butanol, it was 
necessary to include the use of a stabilizer that prevented the aggregation and shrinkage 
problems. 
 
In the “Matrix-assisted colloidosomes” (MACs) and RP-LbL technique method (Chapter 
5), amino-PS microparticles were used as surface stabilizers of the agarose core templates 
in 1-butanol. These agarose templates containing the microparticles, or termed as MACs, 
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neither aggregate nor shrink and could disperse well in 1-butanol. Next, niPA and niPAA, 
dissolved in 1-butanol, were deposited onto these MACs via the RP-LbL technique for the 
fabrication of MAC (core) RP-LbL (shell) microcapsules (Specific Aim 3). The shell 
fabrication was proven successful through the use of fluorescence labeled niPAA (Specific 
Aim 4). The encapsulation and retention efficiency of BSA-FITC within these MAC RP-
LbL microcapsules were demonstrated to be close to 100% and is attributed to the 
polymeric shells that had been fabricated in an organic phase (Specific Aim 5). GOx and 
HRP were also encapsulated within these MAC RP-LbL microcapsules and retained their 
bioactivity (Specific Aim 5). 
 
The second method (agarose/ADOGEN
®
 464 and RP-LbL technique) entails the use of 
ADOGEN
®
 464 (a cationic surfactant) as a stabilizer of agarose core templates in 1-
butanol (Chapter 6). Similarly, no significant aggregation and shrinkage of these 
ADOGEN
®
 464 stabilized agarose templates in 1-butanol was observed. These agarose 
templates were subsequently coated with niPA and niPAA via the RP-LbL technique to 
form the polymeric shells around the templates. The successful fabrication of the 
polymeric shell was proven through the use of fluorescence labeled niPAA and also by the 
possible fabrication of “inflated” microcapsules (Specific Aim 4). Core-shell materials, 
fabricated with 4 bilayers of (niPA/niPAA), were next demonstrated to be able to 
encapsulate and retain dextran with molecular weight of at least 500,000 Da (Specific Aim 
4 & 5). Insignificant loss of dextran (Mw of 500,000 Da) was observed during a 3 day 
incubation from these core-shell materials that were dispersed in an aqueous dispersant. 
However, agarose core-shell materials fabricated with 8 bilayers of (niPA/niPAA) via the 
RP-LbL technique were observed not to be able to efficiently retain dextran of lower 
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molecular weight (65,000 – 76,000 Da and 155,000 Da) over a 3 day incubation period in 
an aqueous dispersant. On the 3
rd
 day, approximately 25% and 30% of the encapsulated 
dextran with molecular weight 65,000 – 76,000 Da and 155,000 Da respectively were 
observed to have remained within these agarose microcapsules of 8 bilayers of 
niPA/niPAA (Specific Aim 4 & 5). 
 
The last method (agarose/ADOGEN
®
 464 and “inwards deposition of concentric niPA 
layers” technique) also involves the use of ADOGEN
®
 464 as a stabilizer of agarose 
microbeads in 1-butanol. Instead of using the RP-LbL technique for fabrication of the 
polymeric shells, a different approach and termed as the “inward deposition of concentric 
niPA layers” technique was used (Chapter 7). This technique has never been reported. 
Unlike polymeric shells fabricated by the RP-LbL technique, where the thickness of these 
shells are usually in the nanometer range and the polymers are deposited in an outwards 
fashion, the thickness of polymeric shells fabricated by the “inward deposition of 
concentric niPA layers” technique can be easily formed in the micrometer range and were 
demonstrated to form by an inwards diffusion and deposition of niPA into the peripheral 
matrices of the agarose core templates. Rather than random adsorption within the matrices 
of agarose templates, the niPA diffuses inwards into the agarose matrices and deposits to 
form concentric layers of near uniform thickness within the templates. Through further 
cross-linking of the niPA polymers followed by heat treatment of the agarose microbeads, 
hollow microcapsules with the cross-linked niPA as polymeric shells could be obtained, 
thus demonstrating the formation of a shell within the agarose core (i.e. successful organic 
phase fabrication of a core-shell material) (Specific Aim 3). The formation of the 
concentric layers occurs through a preferential adsorption of niPA with the hydrophilic 
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agarose polymers followed by complex formation and electrostatic interactions between 
the two polymers (Specific Aim 4). It was also demonstrated that the density and 
thickness of the deposited niPA layers within the matrices of the agarose microbeads can 
be tuned by using different agarose percentage, incubation time and/or niPA quantity 
(Specific Aim 4). The agarose microcapsules fabricated via this third method were 
demonstrated to have easily retained ~95% of dextran (4,000 Da) after a 5 day incubation 
period in an aqueous dispersant (Specific Aim 5). Also, release of encapsulated materials 
could be achieved through the use of cross-linkers possessing cleavable disulfide bonds 
and triggered by a reducing agent. Encapsulation of biomolecules could be performed 
within these microcapsules and with an encoding scheme (Specific Aim 4 & 5). The 
encoding process was performed through the separate incubation of different niPA, having 
different conjugated fluorescence dye, to give a “striated” multi-colored polymeric shell; 
where the colors and thickness of these concentric layers can be permutated to offer up to 
2 levels of encoding possibilities. Through the use of GOx and HRP, it was demonstrated 
that these biomolecules can be encapsulated within these encoded microcapsules and can 
retain their bio-functionality (Specific Aim 5). 
 
To summarize, the works presented thus far in this PhD thesis has demonstrated the 
successful organic phase fabrication of novel core-shell materials that can allow for high 
encapsulation efficiency and retention stability of highly water soluble biomolecules. Such 
properties are especially useful to the development of microcapsule-based bioreactors and 
bioanalytical systems, and for encapsulation of scarce, valuable and expensive proteins. In 
addition, a novel “inwards deposition of concentric niPA layers” technique for the 
fabrication of encoded hydrogel core-shell materials was presented and could contribute 
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significantly to the field of colloidal science and engineering and microencapsulation of 
biomolecules. For example, the unique inwards deposition phenomenon observed could 
lead to further developments of other novel core-shell materials and the encoding system 
can allow for the development of complex and multiplexed microcapsule bio-analytical 
systems. 
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8.2 Future Works 
 
 In this PhD work, only poly(allylamine) and poly(acrylic acid) had been adopted 
for the organic phase fabrication of core-shell material. Use of other polymers such 
as polyvinylpyrrolidone, polyethyleneimine and poly(styrene sulfonic acid) 
dissolved in 1-butanol may be explored as well for the organic phase fabrication of 
the polymeric shells around the agarose core templates. The encapsulation 
efficiency and retention stability of macromolecular biomolecules within the 
different core-shell materials fabricated from different permutations of these 
polymers can be compared as well. 
 
 Agarose is a polysaccharide and temperature sensitive hydrogel that was used for 
the fabrication of the microcapsules. Other hydrogels with different properties may 
be explored for the organic phase fabrication of the hydrogel core-shell materials. 
These include alginic acid, gelatine, polyacrylamide, hyaluronic acid and 
carboxymethylcellulose. 
 
 The “inwards deposition of concentric niPA layers” technique is a novel one that 
can be used for the fabrication of agarose core-shell materials with thick polymeric 
shells. This can be easily performed in a few hours and with good reproducibility. 
However, the exact deposition of niPA within the agarose matrices and diffusion 
kinetics of niPA into the agarose matrices are not yet well understood. To 
understand the deposition mechanism, various polymers of different properties 
(electrostatic charges, hydrophobicity, hydrophilicity and molecular weight) can be 
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incubated with the agarose core templates and studied. Such polymers include 
polyethyleneimine, poly-L-lysine, poly(acrylic acid) and poly(styrene sulfonic 
acid). Diffusion kinetics can be easily understood by measuring the time it takes 
for niPA to completely deposit within the matrices of agarose template of different 
diameters. Computer modeling of the diffusion kinetics with the hypothesized 
deposition mechanism and parameters may be performed for further understanding 
and for comparison between theoretical and experimental results. 
 
 In Chapter 7, it was briefly demonstrated that release of encapsulated materials can 
be achieved via the use of DSP (amino bi-functional cross-linker with a cleavable 
central disulfide group). Other cross-linkers (as mentioned in Chapter 7) along 
with their release profiles and with respect to different thickness of the niPA shell 
used can be studied for possible biomedical applications such as DNA delivery. 
 
 Conjugated polymers have seen immense advances in the field of bioanalysis. Yet, 
most analytical works described are performed in solution or on a solid platform. It 
would be interesting if this unique group of polymers can be encapsulated within 
core-shell materials for biosensing or bioanalytical purposes. 
 
 To improve the uniformity in size distribution of the agarose microcapsules, the 
use of Shirasu Porous Glass membranes (Zhou et al., 2007, 2009) or microfluidics 
can be adopted to ensure that the core templates formed are uniformly sized. 
Automation of the core-shell material fabrication process may even be possible if 
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